سرطان لوزالمعده (Persian Wikipedia)

Popescu-Vâlceanu, Horaţiu-Cristian; Nan, Raluca; Dragut, Ramona; Rusu, Emilia; Ionescu-Tîrgoviste, Constantin (2015). "Pancreatic cancer: epidemiology and risk factors". Proc. Rom. Acad.

archive.org

World Cancer Report. World Health Organization. 2014. Chapter 5.7. ISBN 978-92-832-0429-9.
Alberts SR, Goldberg RM (2009). "Chapter 9: Gastrointestinal tract cancers". In Casciato DA, Territo MC (eds.). Manual of clinical oncology. Lippincott Williams & Wilkins. pp. 188–236. ISBN 978-0-7817-6884-9.
Yadav, D.; Lowenfels, A.B. (2013). "The epidemiology of pancreatitis and pancreatic cancer". Gastroenterology. 144 (6): 1252–1261. doi:10.1053/j.gastro.2013.01.068. PMID 23622135.
Olson, S.H.; Kurtz, R.C. (2013). "Epidemiology of pancreatic cancer and the role of family history". J Surg Oncol. 107 (1): 1–7. doi:10.1002/jso.23149. PMID 22589078.
Easton, D.; Thompson, D.; McGuffog, L.; Haites, N.; Schofield, A. (1999). "Cancer risks in BRCA2 mutation carriers". J Natl Cancer Inst. 91 (15): 1310–1316. PMID 10433620.
Grover, S.; Syngal, S. (2010). "Hereditary pancreatic cancer". Gastroenterology. 139 (4): 1076–1080, 1080.e1-2. doi:10.1053/j.gastro.2010.08.012. PMID 20727885.
Giardiello, F.M.; Offerhaus, G.J.; Lee, D.H.; Krush, A.J.; Tersmette, A.C. (1993). "Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis". Gut. 34 (10): 1394–1396. PMID 8244108.
Maire, F.; Hammel, P.; Terris, B.; Olschwang, S.; O’Toole, D. (2002). "Intraductal papillary and mucinous pancreatic tumour: a new extracolonic tumour in familial adenomatous polyposis". Gut. 51 (3): 446–449. PMID 12171972.
Lowenfels, A.B.; Maisonneuve, P.; DiMagno, E.P.; Elitsur, Y.; Gates, L.K. (1997). "Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group". J Natl Cancer Inst. 89 (6): 442–446. PMID 9091646.
Huxley, R.; Ansary-Moghaddam, A.; Berrington de González, A.; Barzi, F.; Woodward, M. (2005). "Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies". Br J Cancer. 92 (11): 2076–2083. doi:10.1038/sj.bjc.6602619. PMID 15886696.
Risch, H.A.; Lu, L.; Wang, J.; Zhang, W.; Ni, Q. (2013). "ABO blood group and risk of pancreatic cancer: a study in Shanghai and meta-analysis". Am J Epidemiol. 177 (12): 1326–1337. doi:10.1093/aje/kws458. PMID 23652164.
Gold, E.B.; Gordis, L.; Diener, M.D.; Seltser, R.; Boitnott, J.K. (1985). "Diet and other risk factors for cancer of the pancreas". Cancer. 55 (2): 460–467. PMID 3965101.
Chan, J.M.; Wang, F.; Holly, E.A. (2007). "Whole grains and risk of pancreatic cancer in a large population-based case-control study in the San Francisco Bay Area, California". Am J Epidemiol. 166 (10): 1174–1185. doi:10.1093/aje/kwm194. PMID 17881383.
Li, D.; Yeung, S.C.; Hassan, M.M.; Konopleva, M.; Abbruzzese, J.L. (2009). "Antidiabetic therapies affect risk of pancreatic cancer". Gastroenterology. 137 (2): 482–488. doi:10.1053/j.gastro.2009.04.013. PMID 19375425.
Mollberg N, Rahbari NN, Koch M, Hartwig W, Hoeger Y, Büchler MW, Weitz J (December 2011). "Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis". Annals of Surgery. 254 (6): 882–93. doi:10.1097/SLA.0b013e31823ac299. PMID 22064622. S2CID 42685174.

archive.today

Öberg, K; Knigge, U; Kwekkeboom, D; Perren, A; et al. (ESMO Guidelines Working Group) (October 2012). "Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up". Annals of Oncology. 23 Suppl 7 (suppl 7): vii124-30. doi:10.1093/annonc/mds295. PMID 22997445. (Table 5 outlines the proposed TNM staging system for PanNETs.)

books.google.com

Harris RE (2013). "Epidemiology of pancreatic cancer". Epidemiology of Chronic Disease. Jones & Bartlett. pp. 181–190. ISBN 978-0-7637-8047-0. Archived from the original on 24 June 2016.
Handbook of Pancreatic Cancer. New York: Springer. 2009. p. 288. ISBN 978-0-387-77497-8. Archived from the original on 10 September 2017. Retrieved 12 June 2016.
Picozzi VJ (2005). "Pancreatic Cancer: Clinical Presentation". In vonHoff DD, Evans DB, Hruban RH (eds.). Pancreatic Cancer. Jones & Bartlett Learning. pp. 155–164. ISBN 9780763721787.
Werner J, Herzig S (2010). "Paraneoplastic Syndromes in Pancreatic Cancer". In Neoptolemos JP, Urrutia R, Abbruzzese J, Büchler MW (eds.). Pancreatic Cancer. Springer Science & Business Media. pp. 651–673. doi:10.1007/978-0-387-77498-5_27. ISBN 9780387774978.
Javle M, Fisch FM (2010). "Distal Pancreatectomy". In Neoptolemos JP, Urrutia R, Abbruzzese J, Büchler MW (eds.). Pancreatic Cancer. Springer Science & Business Media. pp. 813–838. doi:10.1007/978-0-387-77498-5_33. ISBN 9780387774978.
Gallagher SF, Zervos EE, Murr MM (2005). "Distal Pancreatectomy". In von Hoff DD, Evans DB, Hruban RH (eds.). Pancreatic Cancer. Jones & Bartlett Learning. pp. 299–312. ISBN 9780763721787.
National Institute of Alcohol Abuse and Alcoholism (1995). The physicians’ guide to helping patient with alcohol problems. Wasintong DC: Goverment Printing Office. Retrieved 2 January 2025.

cancer.gov

"Pancreatic Cancer Treatment (PDQ®) Patient Version". National Cancer Institute. National Institutes of Health. 17 April 2014. Archived from the original on 5 July 2014. Retrieved 8 June 2014.
"What Is Cancer? Defining Cancer". National Cancer Institute, National Institutes of Health. 7 March 2014. Archived from the original on 25 June 2014. Retrieved 5 December 2014.
"Pancreatic Cancer Treatment (PDQ®) Health Professional Version". National Cancer Institute. National Institutes of Health. 21 February 2014. Archived from the original on 22 October 2014. Retrieved 24 November 2014.
National Cancer Institute. Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Treatment (PDQ®) Incidence and Mortality "Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Treatment (PDQ®)–Health Professional Version". Archived from the original on 4 January 2015. Retrieved 29 December 2014.
"Cancer Drug Information: FDA Approval for Erlotinib Hydrochloride". National Cancer Institute. National Institutes of Health. 3 ژوئیه 2013. Archived from the original on 29 November 2014. Retrieved 5 December 2014.
"Chemotherapy Regimen Extends Survival in Advanced Pancreatic Cancer Patients". National Cancer Institute. 7 June 2011. Retrieved September 6, 2013.
Everolimus Approved for Pancreatic Neuroendocrine Tumors بایگانی‌شده در ۱۶ ژوئیه ۲۰۱۶ توسط Wayback Machine The ASCO Post. 15 May 2011, Volume 2, Issue 8
National Cancer Institute. Cancer Drug Information. FDA Approval for Sunitinib Malate بایگانی‌شده در ۵ ژانویه ۲۰۱۵ توسط Wayback Machine. Pancreatic Neuroendocrine Tumors

seer.cancer.gov

"Pancreatic Cancer – Cancer Stat Facts". SEER (به انگلیسی). Retrieved 4 April 2019.

cancer.org

"Can pancreatic cancer be prevented?". American Cancer Society. 11 June 2014. Archived from the original on 13 November 2014. Retrieved 13 November 2014.
«Signs and Symptoms of Pancreatic Cancer». The American Cancer Society.
"Cancer Facts and Figures 2014" (PDF). American Cancer Society. Archived (PDF) from the original on 18 December 2014. Retrieved 5 January 2015., p. 19, "Though evidence is still accumulating, consumption of red or processed meat, or meat cooked at very high temperatures, may slightly increase risk."
"Staging of pancreatic cancer". American Cancer Society. 11 June 2014. Archived from the original on 10 August 2020. Retrieved 29 September 2014.
"Diet and activity factors that affect risks for certain cancers: Pancreatic cancer section". American Cancer Society. 20 August 2012. Archived from the original on 4 November 2014. Retrieved 4 November 2014.
"Palliative or Supportive Care". American Cancer Society. 2014. Archived from the original on 21 August 2014. Retrieved 20 August 2014.
"If treatment for pancreatic cancer stops working". American Cancer Society. 11 June 2014. Archived from the original on 22 October 2014. Retrieved 20 August 2014.
"Cancer Facts and Figures 2014" (PDF). American Cancer Society. Archived (PDF) from the original on 18 December 2014. Retrieved 5 January 2015., Table, p. 18, rates adjusted for normal life expectancy
"What are the key statistics about pancreatic cancer?". American Cancer Society. 11 June 2014. Archived from the original on 11 November 2014. Retrieved 11 November 2014.
"What's new in pancreatic cancer research and treatment?". American Cancer Society. 2019. Retrieved 2 May 2019.
"What's new in pancreatic cancer research and treatment?". American Cancer Society. 2019. Retrieved 2 May 2019.

cancernetwork.com

Text is available electronically (but may require free registration) See: Benson AB, Myerson RJ, Sasson AR (2010). Pancreatic, neuroendocrine GI, and adrenal cancers. Cancer Management: A Multidisciplinary Approach (13th ed.). UBM Medica. ISBN 978-0-615-41824-7. Archived from the original on 15 May 2011.

cancerresearchuk.org

"Pancreatic cancer statistics". Cancer Research UK. Archived from the original on 18 December 2014. Retrieved 18 December 2014.; "In 2010, in the UK, the lifetime risk of developing pancreatic cancer is 1 in 73 for men and 1 in 74 for women", noting "The lifetime risk ... has been calculated ... using the 'Current Probability' method; this is a different method used from most other cancer sites since the possibility of having more than one diagnosis of pancreatic cancer over the course of their lifetime is very low"
"Pancreatic cancer research". Cancer Research UK. Archived from the original on 18 February 2014. Retrieved 17 July 2014.

cancerstaging.org

"Chapter 15; Pancreas" (PDF). Manual for Staging of Cancer (2nd ed.). American Joint Committee on Cancer. pp. 95–98. Archived (PDF) from the original on 29 November 2014. See p. 95 for citation regarding "... lesser degree of involvement of bones and brain and other anatomical sites."

clevelandclinic.org

my.clevelandclinic.org

«Pancreatic Cancer». Cleveland Clinic.

creativecommons.org

Hackeng WM, Hruban RH, Offerhaus GJ, Brosens LA (2016). "Surgical and molecular pathology of pancreatic neoplasms". Diagn Pathol. 11 (1): 47. doi:10.1186/s13000-016-0497-z. PMC 4897815. PMID 27267993.{{cite journal}}: نگهداری یادکرد:نام‌های متعدد:فهرست نویسندگان (link) (distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/)), Image title and optimization: Mikael Häggström, M.D.

doi.org

Ryan DP, Hong TS, Bardeesy N (September 2014). "Pancreatic adenocarcinoma". The New England Journal of Medicine. 371 (11): 1039–49. doi:10.1056/NEJMra1404198. PMID 25207767.
Wolfgang CL, Herman JM, Laheru DA, Klein AP, Erdek MA, Fishman EK, Hruban RH (September 2013). "Recent progress in pancreatic cancer". CA: A Cancer Journal for Clinicians. 63 (5): 318–48. doi:10.3322/caac.21190. PMC 3769458. PMID 23856911.
Vincent A, Herman J, Schulick R, Hruban RH, Goggins M (اوت 2011). "Pancreatic cancer" (PDF). Lancet. 378 (9791): 607–20. doi:10.1016/S0140-6736(10)62307-0. PMC 3062508. PMID 21620466. Archived from the original (PDF) on 12 January 2015.
Bond-Smith G, Banga N, Hammond TM, Imber CJ (May 2012). "Pancreatic adenocarcinoma". BMJ. 344 (may16 1): e2476. doi:10.1136/bmj.e2476. PMID 22592847. S2CID 206894869.
Larsson, S. C.; Wolk, A. (2012). "Red and processed meat consumption and risk of pancreatic cancer: meta-analysis of prospective studies". British Journal of Cancer. 106 (3): 603–607. doi:10.1038/bjc.2011.585. PMC 3273353. PMID 22240790.
Rohrmann, Sabine; et al. (2013). "Meat and fish consumption and risk of pancreatic cancer: Results from the European Prospective Investigation into Cancer and Nutrition". International Journal of Cancer. 132 (3): 617–624. doi:10.1002/ijc.27637. PMID 22610753. S2CID 2613568.
Bardou M, Le Ray I (December 2013). "Treatment of pancreatic cancer: A narrative review of cost-effectiveness studies". Best Practice & Research Clinical Gastroenterology. 27 (6): 881–92. doi:10.1016/j.bpg.2013.09.006. PMID 24182608.
Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. (GBD 2015 Mortality and Causes of Death Collaborators) (October 2016). "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015". The Lancet. 388 (10053): 1459–1544. doi:10.1016/s0140-6736(16)31012-1. PMC 5388903. PMID 27733281.
Öberg, K; Knigge, U; Kwekkeboom, D; Perren, A; et al. (ESMO Guidelines Working Group) (October 2012). "Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up". Annals of Oncology. 23 Suppl 7 (suppl 7): vii124-30. doi:10.1093/annonc/mds295. PMID 22997445. (Table 5 outlines the proposed TNM staging system for PanNETs.)
Wang Y, Miller FH, Chen ZE, Merrick L, Mortele KJ, Hoff FL; et al. (2011). "Diffusion-weighted MR imaging of solid and cystic lesions of the pancreas". Radiographics. 31 (3): E47-64. doi:10.1148/rg.313105174. PMID 21721197.{{cite journal}}: نگهداری یادکرد:نام‌های متعدد:فهرست نویسندگان (link). Diagram by Mikael Häggström, M.D.
Jang, SH.; Choi, SY.; Min, JH.; Kim, TW.; Lee, JA.; Byun, SJ.; Lee, JW. (Feb 2010). "[A case of acinar cell carcinoma of pancreas, manifested by subcutaneous nodule as initial clinical symptom]". Korean J Gastroenterol. 55 (2): 139–43. doi:10.4166/kjg.2010.55.2.139. PMID 20168061.
Elta, GH; Enestvedt, BK; Sauer, BG; Lennon, AM (April 2018). "ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts". The American Journal of Gastroenterology. 113 (4): 464–479. doi:10.1038/ajg.2018.14. PMID 29485131. S2CID 3584079.
Farrell JJ, Fernández-del Castillo C (June 2013). "Pancreatic cystic neoplasms: management and unanswered questions". Gastroenterology. 144 (6): 1303–15. doi:10.1053/j.gastro.2013.01.073. PMID 23622140.
The PanNET denomination is in line with WHO guidelines for the classification of tumors of the digestive system "WHO classification of tumours of the digestive system – NLM Catalog – NCBI". Archived from the original on 9 September 2017. Retrieved 7 September 2017. published in 2010. Historically, PanNETs have also been referred to by a variety of terms, and are still commonly called "pancreatic endocrine tumors". See: Klimstra DS, Modlin IR, Coppola D, Lloyd RV, Suster S (August 2010). "The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems". Pancreas. 39 (6): 707–12. doi:10.1097/MPA.0b013e3181ec124e. PMID 20664470. S2CID 3735444.
Burns WR, Edil BH (March 2012). "Neuroendocrine pancreatic tumors: guidelines for management and update". Current Treatment Options in Oncology. 13 (1): 24–34. doi:10.1007/s11864-011-0172-2. PMID 22198808. S2CID 7329783.
Furukawa H, Okada S, Saisho H, Ariyama J, Karasawa E, Nakaizumi A, Nakazawa S, Murakami K, Kakizoe T (1996). "Clinicopathologic features of small pancreatic adenocarcinoma. A collective study". Cancer. 1, 78 (5): 986–990. doi:10.1002/(SICI)1097-0142(19960901)78:5<986::AID-CNCR7>3.0.CO;2-A. PMID 8780535. Retrieved 7 May 2024.{{cite journal}}: نگهداری CS1: نقطه‌گذاری اضافه (link)
Khorana, Alok A; Fine, Robert L. (2004). "Pancreatic cancer and thromboembolic disease". The Lancet Oncology. 5 (11): 655–663. doi:10.1016/S1470-2045(04)01606-7. PMID 15522652. Retrieved 8 May 2024.
Werner J, Herzig S (2010). "Paraneoplastic Syndromes in Pancreatic Cancer". In Neoptolemos JP, Urrutia R, Abbruzzese J, Büchler MW (eds.). Pancreatic Cancer. Springer Science & Business Media. pp. 651–673. doi:10.1007/978-0-387-77498-5_27. ISBN 9780387774978.
Tsuchiya R, Noda T, Harada N, Miyamoto T, Tomioka T, Yamamoto K, Yamaguchi T, Izawa K, Tsunoda T, Yoshino R (1986). "Collective review of small carcinomas of the pancreas". Annals of Surgical Oncology. 203 (1). doi:10.1097/00000658-198601000-00013. PMC 1251042. PMID 3942423. Retrieved 7 May 2024.{{cite journal}}: نگهداری CS1: نقطه‌گذاری اضافه (link) نگهداری یادکرد:فرمت پارامتر PMC (link)
Kalser, Martin H.; Barkin, Jamie; Macintyre, John M. (1985). "Pancreatic cancer. Assessment of prognosis by clinical presentation". Cancer. 56 (2): 397–402. doi:10.1002/1097-0142(19850715)56:2<397::aid-cncr2820560232>3.0.co;2-i. PMID 4005804. Retrieved 8 May 2024.
Manabe T, Miyashita T, Ohshio G, Nonaka A, Suzuki T, Endo K, Takahashi M, Tobe T (1988). "Small carcinoma of the pancreas. Clinical and pathologic evaluation of 17 patients". cancer. 62 (1): 135–141. doi:10.1002/1097-0142(19880701)62:1<135::aid-cncr2820620123>3.0.co;2-t. PMID 3164230. Retrieved 8 May 2024.
Sun, L.; Quan, X.Q.; Yu, S. (2015). "An Epidemiological Survey of Cachexia in Advanced Cancer Patients and Analysis on Its Diagnostic and Treatment Status". Nutr Cancer. 67 (7): 1056–1062. doi:10.1080/01635581.2015.1073753. PMID 26317149.
Tan, C.R.; Yaffee, P.M.; Jamil, L.H.; Lo, S.K.; Nissen, N. (2014). "Pancreatic cancer cachexia: a review of mechanisms and therapeutics". Front Physiol. 5: 88. doi:10.3389/fphys.2014.00088. PMID 24624094.
Mueller, T.C.; Burmeister, M.A.; Bachmann, J.; Martignoni, M.E. (2014). "Cachexia and pancreatic cancer: are there treatment options?". World J Gastroenterol. 20 (28): 9361–9373. doi:10.3748/wjg.v20.i28.9361. PMID 25071331.
Pannala R, Basu A, Petersen GM, Chari ST (January 2009). "New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer". The Lancet. Oncology. 10 (1): 88–95. doi:10.1016/S1470-2045(08)70337-1. PMC 2795483. PMID 19111249.
Porta M, Fabregat X, Malats N, Guarner L, Carrato A, de Miguel A, Ruiz L, Jariod M, Costafreda S, Coll S, Alguacil J, Corominas JM, Sola R, Salas A, Real FX (2005). "Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage". Clinical and Translational Oncology. 7 (5): 189–197. doi:10.1007/BF02712816. Retrieved 7 May 2024.
Pinzon R, Drewinko B, Trujillo JM, Guinee V, Giacco G (1986). "Pancreatic carcinoma and Trousseau's syndrome: experience at a large cancer center". Journal of Clinical Oncology. 4 (4). doi:10.1200/JCO.1986.4.4.509. PMID 3958764. Retrieved 8 May 2024.
Jia, L.; Jiang, S.M.; Shang, Y.Y.; Huang, Y.X.; Li, Y.J. (2010). "Investigation of the incidence of pancreatic cancer-related depression and its relationship with the quality of life of patients". Digestion. 82 (1): 4–9. doi:10.1159/000253864. PMID 20145402.
Mayr, M.; Schmid, R.M. (2010). "Pancreatic cancer and depression: myth and truth". BMC Cancer. 10: 569. doi:10.1186/1471-2407-10-569. PMID 20961421.
Breitbart, W.; Rosenfeld, B.; Tobias, K.; Pessin, H.; Ku, G.Y. (2014). "Depression, cytokines, and pancreatic cancer". Psychooncology. 23 (3): 339–345. doi:10.1002/pon.3422. PMID 24136882.
Javle M, Fisch FM (2010). "Distal Pancreatectomy". In Neoptolemos JP, Urrutia R, Abbruzzese J, Büchler MW (eds.). Pancreatic Cancer. Springer Science & Business Media. pp. 813–838. doi:10.1007/978-0-387-77498-5_33. ISBN 9780387774978.
Ostlere, Lucy S.; Branfoot, Anthony C.; Staughton, Richard Charles D. (1992). "Cicatricial pemphigoid and carcinoma of the pancreas". Clinical and Experimental Dermatology. 17 (1): 67–68. doi:10.1111/j.1365-2230.1992.tb02541.x. PMID 1330387. Retrieved 8 May 2024.
Batabyal, P.; Vander Hoorn, S.; Christophi, C.; Nikfarjam, M. (2014). "Association of diabetes mellitus and pancreatic adenocarcinoma: a meta-analysis of 88 studies". Ann Surg Oncol. 21 (7): 2453–2462. doi:10.1245/s10434-014-3625-6. PMID 24609291.
Sperti C, Moletta L, Patanè G (October 2014). "Metastatic tumors to the pancreas: The role of surgery". World Journal of Gastrointestinal Oncology. 6 (10): 381–92. doi:10.4251/wjgo.v6.i10.381. PMC 4197429. PMID 25320654.
Bosetti C, Lucenteforte E, Silverman DT, Petersen G, Bracci PM, Ji BT, et al. (July 2012). "Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4)". Annals of Oncology. 23 (7): 1880–88. doi:10.1093/annonc/mdr541. PMC 3387822. PMID 22104574.
Yadav, D.; Lowenfels, A.B. (2013). "The epidemiology of pancreatitis and pancreatic cancer". Gastroenterology. 144 (6): 1252–1261. doi:10.1053/j.gastro.2013.01.068. PMID 23622135.
Berger, N.A. (2014). "Obesity and cancer pathogenesis". Ann N Y Acad Sci. 1311: 57–76. doi:10.1111/nyas.12416. PMID 24725147.
Chan, J.M.; Wang, F.; Holly, E.A. (2007). "Pancreatic cancer, animal protein and dietary fat in a population-based study, San Francisco Bay Area, California". Cancer Causes Control. 18 (10): 1153–1167. doi:10.1007/s10552-007-9054-0. PMID 17805983.
Zhang, J.; Dhakal, I.B.; Gross, M.D.; Lang, N.P.; Kadlubar, F.F. (2009). "Physical activity, diet, and pancreatic cancer: a population-based, case-control study in Minnesota". Nutr Cancer. 61 (4): 457–465. doi:10.1080/01635580902718941. PMID 19838917.
Rohrmann, Sabine; et al. (2013). "Meat and fish consumption and risk of pancreatic cancer: Results from the European Prospective Investigation into Cancer and Nutrition". International Journal of Cancer. 132 (3): 617–624. doi:10.1002/ijc.27637. PMID 22610753. S2CID 2613568.
Olson, S.H.; Kurtz, R.C. (2013). "Epidemiology of pancreatic cancer and the role of family history". J Surg Oncol. 107 (1): 1–7. doi:10.1002/jso.23149. PMID 22589078.
Herreros-Villanueva, M.; Hijona, E.; Bañales, J.M.; Cosme, A.; Bujanda, L. (2013). "Alcohol consumption on pancreatic diseases". World J Gastroenterol. 19 (5): 638–647. doi:10.3748/wjg.v19.i5.638. PMID 23429423.
Kloner, Robert A.; Rezkalla, Shereif H. (2007). "To drink or not to drink? That is the question". Circulation. 116 (11): 1306–1317. doi:10.1161/CIRCULATIONAHA.106.678375. PMID 17846344. Retrieved 2 January 2025.
Kerr, William C; Greenfield, Thomas K; Tujague, Jennifer; Brown, Stephan E (2005). "A drink is a drink? Variation in the amount of alcohol contained in beer, wine and spirits drinks in a US methodological sample". Alcoholism: Clinical and Experimental Research. 29 (11): 2015–2021. doi:10.1097/01.alc.0000187596.92804.bd. PMID 16340459. Retrieved 2 January 2025.
Genkinger, J.M.; Spiegelman, D.; Anderson, K.E.; Bergkvist, L.; Bernstein, L. (2009). "Alcohol intake and pancreatic cancer risk: a pooled analysis of fourteen cohort studies". Cancer Epidemiol Biomarkers Prev. 18 (3): 765–776. doi:10.1158/1055-9965.EPI-08-0880. PMID 19258474.
Lucenteforte, E.; La Vecchia, C.; Silverman, D.; Petersen, G.M.; Bracci, P.M. (2012). "Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4)". Ann Oncol. 23 (2): 374–382. doi:10.1093/annonc/mdr120. PMID 21536662.
Tramacere, I.; Scotti, L.; Jenab, M.; Bagnardi, V.; Bellocco, R. (2010). "Alcohol drinking and pancreatic cancer risk: a meta-analysis of the dose-risk relation". Int J Cancer. 126 (6): 1474–1486. doi:10.1002/ijc.24936. PMID 19816941.
Peters ML, Tseng JF, Miksad RA (July 2016). "Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment". Clinical Therapeutics. 38 (7): 1622–35. doi:10.1016/j.clinthera.2016.03.006. PMID 27041411.
Rustgi, A.K. (2014). "Familial pancreatic cancer: genetic advances". Genes Dev. 28 (1): 1–7. doi:10.1101/gad.228452.113. PMID 24395243.
Korsse, S.E.; Harinck, F.; van Lier, M.G.; Biermann, K.; Offerhaus, G.J. (2013). "Pancreatic cancer risk in Peutz-Jeghers syndrome patients: a large cohort study and implications for surveillance". J Med Genet. 50 (1): 59–64. doi:10.1136/jmedgenet-2012-101277. PMID 23240097.
Hsu FC, Roberts NJ, Childs E, Porter N, Rabe KG, Borgida A, Ukaegbu C, Goggins MG, Hruban RH, Zogopoulos G, Syngal S, Gallinger S, Petersen GM, Klein AP (2021). "Risk of Pancreatic Cancer Among Individuals With Pathogenic Variants in the ATM Gene". JAMA Oncol. 7 (11): 1664–1668. doi:10.1001/jamaoncol.2021.3701. PMC 8446906. PMID 34529012. Retrieved 17 May 2024.
Hannan Z, Yu S, Domchek S, Mamtani R, Reiss KA (2021). "Clinical Characteristics of Patients With Pancreatic Cancer and Pathogenic ATM Alterations". JNCI Cancer Spectr. 5 (2): 1–4. doi:10.1093/jncics/pkaa121. PMC 7952223. PMID 33733050. Retrieved 17 May 2024.
Grover, S.; Syngal, S. (2010). "Hereditary pancreatic cancer". Gastroenterology. 139 (4): 1076–1080, 1080.e1-2. doi:10.1053/j.gastro.2010.08.012. PMID 20727885.
Geary, J.; Sasieni, P.; Houlston, R.; Izatt, L.; Eeles, R. (2008). "Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC)". Fam Cancer. 7 (2): 163–172. doi:10.1007/s10689-007-9164-6. PMID 17939062.
Raimondi, S.; Lowenfels, A.B.; Morselli-Labate, A.M.; Maisonneuve, P.; Pezzilli, R. (2010). "Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection". Best Pract Res Clin Gastroenterol. 24 (3): 349–358. doi:10.1016/j.bpg.2010.02.007. PMID 20510834.
Becker, A.E.; Hernandez, Y.G.; Frucht, H.; Lucas, A.L. (2014). "Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection". World J Gastroenterol. 20 (32): 11182–11198. doi:10.3748/wjg.v20.i32.11182. PMID 25170203.
Reznik R, Hendifar AE, Tuli R (2014). "Genetic determinants and potential therapeutic targets for pancreatic adenocarcinoma". Frontiers in Physiology. 5: 87. doi:10.3389/fphys.2014.00087. PMC 3939680. PMID 24624093.
Paliwal, S.; Bhaskar, S.; Chandak, G.R. (2014). "Genetic and phenotypic heterogeneity in tropical calcific pancreatitis". World J Gastroenterol. 20 (46): 17314–17323. doi:10.3748/wjg.v20.i46.17314. PMID 25516642.
Huxley, R.; Ansary-Moghaddam, A.; Berrington de González, A.; Barzi, F.; Woodward, M. (2005). "Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies". Br J Cancer. 92 (11): 2076–2083. doi:10.1038/sj.bjc.6602619. PMID 15886696.
Li, D.; Tang, H.; Hassan, M.M.; Holly, E.A.; Bracci, P.M. (2011). "Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies". Cancer Causes Control. 22 (2): 189–197. doi:10.1007/s10552-010-9686-3. PMID 21104117.
Hagymási, K.; Tulassay, Z. (2014). "Helicobacter pylori infection: new pathogenetic and clinical aspects". World J Gastroenterol. 20 (21): 6386–6399. doi:10.3748/wjg.v20.i21.6386. PMID 24914360.
Bulajic, M.; Panic, N.; Löhr, J.M. (2014). "Helicobacter pylori and pancreatic diseases". World J Gastrointest Pathophysiol. 5 (4): 380–383. doi:10.4291/wjgp.v5.i4.380. PMID 25400980.
Michaud, D.S. (2013). "Role of bacterial infections in pancreatic cancer". Carcinogenesis. 34 (10): 2193–2197. doi:10.1093/carcin/bgt249. PMID 23843038.
Risch, H.A.; Lu, L.; Wang, J.; Zhang, W.; Ni, Q. (2013). "ABO blood group and risk of pancreatic cancer: a study in Shanghai and meta-analysis". Am J Epidemiol. 177 (12): 1326–1337. doi:10.1093/aje/kws458. PMID 23652164.
Egawa, N.; Lin, Y.; Tabata, T.; Kuruma, S.; Hara, S. (2013). "ABO blood type, long-standing diabetes, and the risk of pancreatic cancer". World J Gastroenterol. 19 (16): 2537–2542. doi:10.3748/wjg.v19.i16.2537. PMID 23674856.
Karoumpalis, Ioannis; Christodoulou, Dimitrios K (2016). "Cystic lesions of the pancreas". Annals of Gastroenterology. 29 (2): 155–161. doi:10.20524/aog.2016.0007. PMID 27065727. Retrieved 2 January 2025.
Hackeng WM, Hruban RH, Offerhaus GJ, Brosens LA (2016). "Surgical and molecular pathology of pancreatic neoplasms". Diagn Pathol. 11 (1): 47. doi:10.1186/s13000-016-0497-z. PMC 4897815. PMID 27267993.{{cite journal}}: نگهداری یادکرد:نام‌های متعدد:فهرست نویسندگان (link) (distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/)), Image title and optimization: Mikael Häggström, M.D.
Delpu Y, Hanoun N, Lulka H, Sicard F, Selves J, Buscail L, et al. (March 2011). "Genetic and epigenetic alterations in pancreatic carcinogenesis". Current Genomics. 12 (1): 15–24. doi:10.2174/138920211794520132. PMC 3129039. PMID 21886451.
Rooney SL, Shi J (October 2016). "Intraductal Tubulopapillary Neoplasm of the Pancreas: An Update From a Pathologist's Perspective". Archives of Pathology & Laboratory Medicine. 140 (10): 1068–73. doi:10.5858/arpa.2016-0207-RA. PMID 27684978.
Uhlen M, Zhang C, Lee S, Sjöstedt E, Fagerberg L, Bidkhori G, et al. (August 2017). "A pathology atlas of the human cancer transcriptome". Science. 357 (6352): eaan2507. doi:10.1126/science.aan2507. PMID 28818916.
Lewis MA, Yao JC (February 2014). "Molecular pathology and genetics of gastrointestinal neuroendocrine tumours". Current Opinion in Endocrinology, Diabetes and Obesity. 21 (1): 22–27. doi:10.1097/MED.0000000000000033. PMID 24310147. S2CID 31094880.
Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, et al. (September 2012). "Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)". The Journal of Clinical Endocrinology and Metabolism. 97 (9): 2990–3011. doi:10.1210/jc.2012-1230. PMID 22723327.
Artinyan, A.; Soriano, P.A.; Prendergast, C.; Low, T.; Ellenhorn, J.D. (2008). "The anatomic location of pancreatic cancer is a prognostic factor for survival". HPB (Oxford). 10 (5): 371–376. doi:10.1080/13651820802291233. PMID 18982154.
Fitzgerald JE, White MJ, Lobo DN (April 2009). "Courvoisier's gallbladder: law or sign?". World Journal of Surgery. 33 (4): 886–91. doi:10.1007/s00268-008-9908-y. PMID 19190960. S2CID 21799234.
Skafida E, Grammatoglou X, Glava C, Zissis D, Paschalidis N, Katsamagkou E, et al. (February 2010). "Adenosquamous carcinoma of the pancreas: a case report". Cases Journal. 3 (1): 41. doi:10.1186/1757-1626-3-41. PMC 2825199. PMID 20205828.
Adsay V, Mino-Kenudson M, Furukawa T, Basturk O, Zamboni G, Marchegiani G, et al. (January 2016). "Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting". Annals of Surgery. 263 (1): 162–77. doi:10.1097/SLA.0000000000001173. PMC 4568174. PMID 25775066.
Cascinu S, Falconi M, Valentini V, Jelic S (May 2010). "Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up". Annals of Oncology. 21 Suppl 5 (Supplement 5): v55–58. doi:10.1093/annonc/mdq165. PMID 20555103.
Satoshi Kondo. "Japanese Pancreas Society Staging Systems for Pancreatic Cancer". Pancreatic cancer. Springer New York. doi:10.1007/978-0-387-77498-5_42. ISBN 978-0-387-77497-8.
Chan, J.M.; Wang, F.; Holly, E.A. (2005). "Vegetable and fruit intake and pancreatic cancer in a population-based case-control study in the San Francisco bay area". Cancer Epidemiol Biomarkers Prev. 14 (9): 2093–2097. doi:10.1158/1055-9965.EPI-05-0226. PMID 16172215.
Chan, J.M.; Wang, F.; Holly, E.A. (2007). "Whole grains and risk of pancreatic cancer in a large population-based case-control study in the San Francisco Bay Area, California". Am J Epidemiol. 166 (10): 1174–1185. doi:10.1093/aje/kwm194. PMID 17881383.
Sun, J.; Li, Y.; Liu, L.; Jiang, Z.; Liu, G. (2019). "Aspirin use and pancreatic cancer risk: A systematic review of observational studies - PubMed". Medicine. 98 (51): e18033. doi:10.1097/MD.0000000000018033. PMC 6940047. PMID 31860953.
Currie, C.J.; Poole, C.D.; Gale, E.A. (2009). "The influence of glucose-lowering therapies on cancer risk in type 2 diabetes". Diabetologia. 52 (9): 1766–1777. doi:10.1007/s00125-009-1440-6. PMID 19572116.
Li, D.; Yeung, S.C.; Hassan, M.M.; Konopleva, M.; Abbruzzese, J.L. (2009). "Antidiabetic therapies affect risk of pancreatic cancer". Gastroenterology. 137 (2): 482–488. doi:10.1053/j.gastro.2009.04.013. PMID 19375425.
Decensi, A.; Puntoni, M.; Goodwin, P.; Cazzaniga, M.; Gennari, A. (2010). "Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis". Cancer Prev Res (Phila). 3 (11): 1451–1461. doi:10.1158/1940-6207.CAPR-10-0157. PMID 20947488.
Li, D. (2012). "Diabetes and pancreatic cancer". Mol Carcinog. 51 (1): 64–74. doi:10.1002/mc.20771. PMID 22162232.
Monami, M.; Lamanna, C.; Balzi, D.; Marchionni, N.; Mannucci, E. (2009). "Sulphonylureas and cancer: a case-control study". Acta Diabetol. 46 (4): 279–284. doi:10.1007/s00592-008-0083-2. PMID 19082520.
He XY, Yuan YZ (August 2014). "Advances in pancreatic cancer research: moving towards early detection". World Journal of Gastroenterology. 20 (32): 11241–48. doi:10.3748/wjg.v20.i32.11241. PMC 4145762. PMID 25170208.
Okano K, Suzuki Y (August 2014). "Strategies for early detection of resectable pancreatic cancer". World Journal of Gastroenterology. 20 (32): 11230–40. doi:10.3748/wjg.v20.i32.11230. PMC 4145761. PMID 25170207.
Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, et al. (August 2019). "Screening for Pancreatic Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement". JAMA. 322 (5): 438–44. doi:10.1001/jama.2019.10232. PMID 31386141.
Seufferlein T, Bachet JB, Van Cutsem E, Rougier P (October 2012). "Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up". Annals of Oncology. 23 (Suppl 7): vii33–40. doi:10.1093/annonc/mds224. PMID 22997452.
Goggins M, Overbeek KA, Brand R, Syngal S, Del Chiaro M, Bartsch DK, et al. (January 2020). "Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium". Gut. 69 (1): 7–17. doi:10.1136/gutjnl-2019-319352. PMC 7295005. PMID 31672839.
Gurusamy KS, Kumar S, Davidson BR, Fusai G (February 2014). "Resection versus other treatments for locally advanced pancreatic cancer". The Cochrane Database of Systematic Reviews. 2 (2): CD010244. doi:10.1002/14651858.CD010244.pub2. PMID 24578248.
Mollberg N, Rahbari NN, Koch M, Hartwig W, Hoeger Y, Büchler MW, Weitz J (December 2011). "Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis". Annals of Surgery. 254 (6): 882–93. doi:10.1097/SLA.0b013e31823ac299. PMID 22064622. S2CID 42685174.
Heinemann V, Haas M, Boeck S (October 2013). "Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancer". Annals of Oncology. 24 (10): 2484–92. doi:10.1093/annonc/mdt239. PMID 23852311.
Conroy, T; Desseigne, F; Ychou, M; et al, on behalf of Groupe Tumeurs Digestives of Unicancer, PRODIGE Intergroup (2011). "FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer". New England Journal of Medicine. 364 (19): 1817–1825. doi:10.1056/nejmoa1011923. PMID 21561347.{{cite journal}}: نگهداری یادکرد:نام‌های متعدد:فهرست نویسندگان (link)
Borazanci E, Von Hoff DD (September 2014). "Nab-paclitaxel and gemcitabine for the treatment of patients with metastatic pancreatic cancer". Expert Review of Gastroenterology & Hepatology. 8 (7): 739–47. doi:10.1586/17474124.2014.925799. PMID 24882381. S2CID 31633898.
Neoptolemos, Jp; Dunn, Ja; Stocken, Dd; Almond, J; Link, K; Beger, H; Bassi, C; Falconi, M; Pederzoli, P; Dervenis, C; Fernandez-Cruz, L (November 2001). "Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial". The Lancet (به انگلیسی). 358 (9293): 1576–1585. doi:10.1016/S0140-6736(01)06651-X. PMID 11716884. S2CID 23803289.
Neoptolemos, John P.; Stocken, Deborah D.; Friess, Helmut; Bassi, Claudio; Dunn, Janet A.; Hickey, Helen; Beger, Hans; Fernandez-Cruz, Laureano; Dervenis, Christos; Lacaine, François; Falconi, Massimo (2004-03-18). "A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer". New England Journal of Medicine (به انگلیسی). 350 (12): 1200–1210. doi:10.1056/NEJMoa032295. ISSN 0028-4793. PMID 15028824.
Falconi M, Bartsch DK, Eriksson B, Klöppel G, Lopes JM, O'Connor JM, et al. (2012). "ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors". Neuroendocrinology. 95 (2): 120–34. doi:10.1159/000335587. PMID 22261872. S2CID 6985904.
Jensen RT, Cadiot G, Brandi ML, de Herder WW, Kaltsas G, Komminoth P, et al. (2012). "ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes". Neuroendocrinology. 95 (2): 98–119. doi:10.1159/000335591. PMC 3701449. PMID 22261919.
Pavel M, Baudin E, Couvelard A, Krenning E, Öberg K, Steinmüller T, et al. (2012). "ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary". Neuroendocrinology. 95 (2): 157–76. doi:10.1159/000335597. PMID 22262022. S2CID 2097604.
Rossi RE, Massironi S, Conte D, Peracchi M (January 2014). "Therapy for metastatic pancreatic neuroendocrine tumors". Annals of Translational Medicine. 2 (1): 8. doi:10.3978/j.issn.2305-5839.2013.03.01. PMC 4200651. PMID 25332984.
Gulenchyn KY, Yao X, Asa SL, Singh S, Law C (May 2012). "Radionuclide therapy in neuroendocrine tumours: a systematic review". Clinical Oncology. 24 (4): 294–308. doi:10.1016/j.clon.2011.12.003. PMID 22221516.
Vinik AI (November 2014). "Advances in diagnosis and treatment of pancreatic neuroendocrine tumors". Endocrine Practice. 20 (11): 1222–30. doi:10.4158/EP14373.RA. PMID 25297671.
Kwekkeboom DJ, de Herder WW, van Eijck CH, Kam BL, van Essen M, Teunissen JJ, Krenning EP (March 2010). "Peptide receptor radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumors". Seminars in Nuclear Medicine. 40 (2): 78–88. doi:10.1053/j.semnuclmed.2009.10.004. PMID 20113677.
Bodei L, Cremonesi M, Kidd M, Grana CM, Severi S, Modlin IM, Paganelli G (August 2014). "Peptide receptor radionuclide therapy for advanced neuroendocrine tumors". Thoracic Surgery Clinics. 24 (3): 333–49. doi:10.1016/j.thorsurg.2014.04.005. hdl:11392/2378236. PMID 25065935.
Castellano D, Grande E, Valle J, Capdevila J, Reidy-Lagunes D, O'Connor JM, Raymond E (June 2015). "Expert consensus for the management of advanced or metastatic pancreatic neuroendocrine and carcinoid tumors". Cancer Chemotherapy and Pharmacology. 75 (6): 1099–114. doi:10.1007/s00280-014-2642-2. PMID 25480314. S2CID 39434924.
Singh S, Dey C, Kennecke H, Kocha W, Maroun J, Metrakos P, et al. (August 2015). "Consensus Recommendations for the Diagnosis and Management of Pancreatic Neuroendocrine Tumors: Guidelines from a Canadian National Expert Group". Annals of Surgical Oncology. 22 (8): 2685–99. doi:10.1245/s10434-014-4145-0. PMID 25366583. S2CID 8129133.
Buanes TA (August 2014). "Pancreatic cancer-improved care achievable". World Journal of Gastroenterology. 20 (30): 10405–18. doi:10.3748/wjg.v20.i30.10405. PMC 4130847. PMID 25132756.
Bilimoria, K.Y.; Bentrem, D.J.; Ko, C.Y.; Ritchey, J.; Stewart, A.K. (2007). "Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database". Cancer. 110 (4): 738–744. doi:10.1002/cncr.22852. PMID 17580363.
Sun, H.; Ma, H.; Hong, G.; Sun, H.; Wang, J. (2014). "Survival improvement in patients with pancreatic cancer by decade: a period analysis of the SEER database, 1981–2010". Sci Rep. 4: 6747. doi:10.1038/srep06747. PMID 25339498.
Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007). "Cancer statistics, 2007". CA: A Cancer Journal for Clinicians. 57 (1): 43–66. doi:10.3322/canjclin.57.1.43. PMID 17237035. S2CID 22305510.
Busnardo AC, DiDio LJ, Tidrick RT, Thomford NR (November 1983). "History of the pancreas". American Journal of Surgery. 146 (5): 539–50. doi:10.1016/0002-9610(83)90286-6. PMID 6356946.
Are C, Dhir M, Ravipati L (June 2011). "History of pancreaticoduodenectomy: early misconceptions, initial milestones and the pioneers". HPB. 13 (6): 377–84. doi:10.1111/j.1477-2574.2011.00305.x. PMC 3103093. PMID 21609369.
Cameron JL, Riall TS, Coleman J, Belcher KA (July 2006). "One thousand consecutive pancreaticoduodenectomies". Annals of Surgery. 244 (1): 10–5. doi:10.1097/01.sla.0000217673.04165.ea. PMC 1570590. PMID 16794383.
Fernández-del Castillo C, Morales-Oyarvide V, McGrath D, Wargo JA, Ferrone CR, Thayer SP, et al. (September 2012). "Evolution of the Whipple procedure at the Massachusetts General Hospital". Surgery. 152 (3 Suppl 1): S56-63. doi:10.1016/j.surg.2012.05.022. PMC 3806095. PMID 22770961.
Reznik R, Hendifar AE, Tuli R (2014). "Genetic determinants and potential therapeutic targets for pancreatic adenocarcinoma". Frontiers in Physiology. 5: 87. doi:10.3389/fphys.2014.00087. PMC 3939680. PMID 24624093.
Biankin AV, Waddell N, Kassahn KS, Gingras MC, Muthuswamy LB, Johns AL, et al. (November 2012). "Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes". Nature. 491 (7424): 399–405. Bibcode:2012Natur.491..399.. doi:10.1038/nature11547. PMC 3530898. PMID 23103869.
Feng, Hui-Yi; Chen, Yang-Chao (2016-09-07). "Role of bile acids in carcinogenesis of pancreatic cancer: An old topic with new perspective". World Journal of Gastroenterology. 22 (33): 7463–7477. doi:10.3748/wjg.v22.i33.7463. ISSN 1007-9327. PMC 5011662. PMID 27672269.
Graham JS, Jamieson NB, Rulach R, Grimmond SM, Chang DK, Biankin AV (September 2015). "Pancreatic cancer genomics: where can the science take us?". Clinical Genetics. 88 (3): 213–9. doi:10.1111/cge.12536. PMID 25388820. S2CID 26414866.
Bruenderman EH, Martin RC (March 2015). "High-risk population in sporadic pancreatic adenocarcinoma: guidelines for screening". The Journal of Surgical Research. 194 (1): 212–9. doi:10.1016/j.jss.2014.06.046. PMC 4559279. PMID 25479908.
Subar D, Gobardhan PD, Gayet B (February 2014). "Laparoscopic pancreatic surgery: An overview of the literature and experiences of a single center". Best Practice & Research. Clinical Gastroenterology. 28 (1): 123–32. doi:10.1016/j.bpg.2013.11.011. PMID 24485260.
Weiss MJ, Wolfgang CL (2013). "Irreversible electroporation: a novel pancreatic cancer therapy". Current Problems in Cancer. 37 (5): 262–5. doi:10.1016/j.currproblcancer.2013.10.002. PMID 24331180. S2CID 3137300.
Moir J, White SA, French JJ, Littler P, Manas DM (December 2014). "Systematic review of irreversible electroporation in the treatment of advanced pancreatic cancer". European Journal of Surgical Oncology. 40 (12): 1598–604. doi:10.1016/j.ejso.2014.08.480. PMID 25307210.
Kleger A, Perkhofer L, Seufferlein T (July 2014). "Smarter drugs emerging in pancreatic cancer therapy". Annals of Oncology. 25 (7): 1260–1270. doi:10.1093/annonc/mdu013. PMID 24631947.
Tang SC, Chen YC (اوت 2014). "Novel therapeutic targets for pancreatic cancer". World Journal of Gastroenterology. 20 (31): 10825–44. doi:10.3748/wjg.v20.i31.10825. PMC 4138462. PMID 25152585.
Tanase CP, Neagu AI, Necula LG, Mambet C, Enciu AM, Calenic B, et al. (August 2014). "Cancer stem cells: involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics". World Journal of Gastroenterology. 20 (31): 10790–801. doi:10.3748/wjg.v20.i31.10790. PMC 4138459. PMID 25152582.
Tang SC, Chen YC (اوت 2014). "Novel therapeutic targets for pancreatic cancer". World Journal of Gastroenterology. 20 (31): 10825–44. doi:10.3748/wjg.v20.i31.10825. PMC 4138462. PMID 25152585.
Rossi ML, Rehman AA, Gondi CS (August 2014). "Therapeutic options for the management of pancreatic cancer". World Journal of Gastroenterology. 20 (32): 11142–59. doi:10.3748/wjg.v20.i32.11142. PMC 4145755. PMID 25170201.
Ady JW, Heffner J, Klein E, Fong Y (2014). "Oncolytic viral therapy for pancreatic cancer: current research and future directions". Oncolytic Virotherapy. 3: 35–46. doi:10.2147/OV.S53858. PMC 4918362. PMID 27512661.
Ren B, Cui M, Yang G, Wang H, Feng M, You L, Zhao Y (July 2018). "Tumor microenvironment participates in metastasis of pancreatic cancer". Molecular Cancer. 17 (1): 108. doi:10.1186/s12943-018-0858-1. PMC 6065152. PMID 30060755.
Sachi Das, Sabya; Kumar Dubey, Amit; Singh, Neeru; Ranjan, Priya; Verma, Prasad; Kumar Singh, Shubhankar; Kumar Singh, Sandeep (2023-01-09). "Pancreatic Cancer Treatment by Using Theragnostic Nanoparticles". Hormone Related Cancer Mechanistic and Nanomedicines. pp. 149–168. doi:10.1007/978-981-19-5558-7_8. ISBN 978-981-19-5557-0.

elsevier.com

linkinghub.elsevier.com

Neoptolemos, Jp; Dunn, Ja; Stocken, Dd; Almond, J; Link, K; Beger, H; Bassi, C; Falconi, M; Pederzoli, P; Dervenis, C; Fernandez-Cruz, L (November 2001). "Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial". The Lancet (به انگلیسی). 358 (9293): 1576–1585. doi:10.1016/S0140-6736(01)06651-X. PMID 11716884. S2CID 23803289.

europac-org.eu

"About EUROPAC". European Registry of Hereditary Pancreatitis and Familial Pancreatic Cancer (EUROPAC). University of Liverpool. Archived from the original on 26 July 2014. Retrieved 17 July 2014.

google.pl

books.google.pl

Meuten, Donald J. (2008). Tumors in Domestic Animals. John Wiley & Sons. pp. 478–480. ISBN 9780470376706.
McManus, Linda M.; Mitchell, Richard N. (2014). Pathobiology of Human Disease: A Dynamic Encyclopedia of Disease Mechanisms. Elsevier. p. 1110. ISBN 9780123864574.
Moulton, Jack E. (1978). Tumors in Domestic Animals. University of California Press. p. 273. ISBN 9780520023864.
Cruickshank, Alan H. (2012). Pathology of the Pancreas. Springer Science & Business Media. p. 150. ISBN 9781447133292.
Withrow, Stephen J.; Vail, David M.; Page, Rodney (2013). Withrow and MacEwen’s Small Animal Clinical Oncology. Elsevier Health Sciences. p. 401. ISBN 9780323241977.

handle.net

hdl.handle.net

Bodei L, Cremonesi M, Kidd M, Grana CM, Severi S, Modlin IM, Paganelli G (August 2014). "Peptide receptor radionuclide therapy for advanced neuroendocrine tumors". Thoracic Surgery Clinics. 24 (3): 333–49. doi:10.1016/j.thorsurg.2014.04.005. hdl:11392/2378236. PMID 25065935.

harvard.edu

ui.adsabs.harvard.edu

Biankin AV, Waddell N, Kassahn KS, Gingras MC, Muthuswamy LB, Johns AL, et al. (November 2012). "Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes". Nature. 491 (7424): 399–405. Bibcode:2012Natur.491..399.. doi:10.1038/nature11547. PMC 3530898. PMID 23103869.

hopkinsmedicine.org

"Pancreatic Cancer Types". hopkinsmedicine.org. Johns Hopkins. December 2024. Retrieved 29 December 2024.
«Pancreatic Cancer Symptoms». Johns Hopkins Medicine.

jhu.edu

pathology.jhu.edu

"Types of Pancreas Tumors". The Sol Goldman Pancreas Cancer Research Center. Johns Hopkins Medicine. 2012. Archived from the original on 8 October 2014. Retrieved 18 November 2014.
"Islet Cell Tumors of the Pancreas / Endocrine Neoplasms of the Pancreas". The Sol Goldman Pancreas Cancer Research Center. Johns Hopkins Medicine. 2012. Archived from the original on 5 January 2015. Retrieved 5 January 2015.

lwwoncology.com

Zyromski, Nicholas J.; Nakeeb, Attila; Lillemoe, Keith D. (2010). Silberman, Howard; Silberman, Allan W. (eds.). Principles and practice of surgical oncology : multidisciplinary approach to difficult problems (online ed.). Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins. Chapter 35. ISBN 978-0-7817-6546-6. Archived from the original on 6 February 2015. Retrieved 3 November 2014.

medscape.com

Nick Mulcahy (17 December 2014). "FDA Approves Lanreotide for Neuroendocrine Tumors". Medscape Medical News. WebMD LLC. Archived from the original on 18 January 2015. Retrieved 25 December 2014.

mp.pl

"Nowotwory części zewnątrz- i wewnątrzwydzielniczej trzustki. Klasyfikacja TNM". Archived from the original on 2015-10-03. Retrieved 2015-10-03.

nature.com

Sun, H.; Ma, H.; Hong, G.; Sun, H.; Wang, J. (2014). "Survival improvement in patients with pancreatic cancer by decade: a period analysis of the SEER database, 1981–2010". Sci Rep. 4: 6747. doi:10.1038/srep06747. PMID 25339498.

nccn.org

"Neuroendocrine tumors, NCCN Guidelines Version 1.2015" (PDF). National Comprehensive Cancer Network, Inc. NCCN). 11 November 2014. Retrieved 25 December 2014.

ncii.ir

old.ncii.ir

«واژه‌نامه سرطان». موسسه تحقیقات، درمان و آموزش سرطان (مرکز جامع سرطان، دانشگاه علوم پزشکی تهران).
«واژه‌نامه سرطان». موسسه تحقیقات، درمان و آموزش سرطان (مرکز جامع سرطان، دانشگاه علوم پزشکی تهران).

nhs.uk

«Symptoms of pancreatic cancer». The National Health Service (NHS).

nih.gov

pubmed.ncbi.nlm.nih.gov

Ryan DP, Hong TS, Bardeesy N (September 2014). "Pancreatic adenocarcinoma". The New England Journal of Medicine. 371 (11): 1039–49. doi:10.1056/NEJMra1404198. PMID 25207767.
Wolfgang CL, Herman JM, Laheru DA, Klein AP, Erdek MA, Fishman EK, Hruban RH (September 2013). "Recent progress in pancreatic cancer". CA: A Cancer Journal for Clinicians. 63 (5): 318–48. doi:10.3322/caac.21190. PMC 3769458. PMID 23856911.
Vincent A, Herman J, Schulick R, Hruban RH, Goggins M (اوت 2011). "Pancreatic cancer" (PDF). Lancet. 378 (9791): 607–20. doi:10.1016/S0140-6736(10)62307-0. PMC 3062508. PMID 21620466. Archived from the original (PDF) on 12 January 2015.
Unless otherwise specified in boxes, reference is: Pishvaian MJ, Brody JR (March 2017). "Therapeutic Implications of Molecular Subtyping for Pancreatic Cancer". Oncology. 31 (3): 159–66, 168. PMID 28299752.
Bond-Smith G, Banga N, Hammond TM, Imber CJ (May 2012). "Pancreatic adenocarcinoma". BMJ. 344 (may16 1): e2476. doi:10.1136/bmj.e2476. PMID 22592847. S2CID 206894869.
Larsson, S. C.; Wolk, A. (2012). "Red and processed meat consumption and risk of pancreatic cancer: meta-analysis of prospective studies". British Journal of Cancer. 106 (3): 603–607. doi:10.1038/bjc.2011.585. PMC 3273353. PMID 22240790.
Rohrmann, Sabine; et al. (2013). "Meat and fish consumption and risk of pancreatic cancer: Results from the European Prospective Investigation into Cancer and Nutrition". International Journal of Cancer. 132 (3): 617–624. doi:10.1002/ijc.27637. PMID 22610753. S2CID 2613568.
Bardou M, Le Ray I (December 2013). "Treatment of pancreatic cancer: A narrative review of cost-effectiveness studies". Best Practice & Research Clinical Gastroenterology. 27 (6): 881–92. doi:10.1016/j.bpg.2013.09.006. PMID 24182608.
Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. (GBD 2015 Mortality and Causes of Death Collaborators) (October 2016). "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015". The Lancet. 388 (10053): 1459–1544. doi:10.1016/s0140-6736(16)31012-1. PMC 5388903. PMID 27733281.
Öberg, K; Knigge, U; Kwekkeboom, D; Perren, A; et al. (ESMO Guidelines Working Group) (October 2012). "Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up". Annals of Oncology. 23 Suppl 7 (suppl 7): vii124-30. doi:10.1093/annonc/mds295. PMID 22997445. (Table 5 outlines the proposed TNM staging system for PanNETs.)
Wang Y, Miller FH, Chen ZE, Merrick L, Mortele KJ, Hoff FL; et al. (2011). "Diffusion-weighted MR imaging of solid and cystic lesions of the pancreas". Radiographics. 31 (3): E47-64. doi:10.1148/rg.313105174. PMID 21721197.{{cite journal}}: نگهداری یادکرد:نام‌های متعدد:فهرست نویسندگان (link). Diagram by Mikael Häggström, M.D.
Jang, SH.; Choi, SY.; Min, JH.; Kim, TW.; Lee, JA.; Byun, SJ.; Lee, JW. (Feb 2010). "[A case of acinar cell carcinoma of pancreas, manifested by subcutaneous nodule as initial clinical symptom]". Korean J Gastroenterol. 55 (2): 139–43. doi:10.4166/kjg.2010.55.2.139. PMID 20168061.
Elta, GH; Enestvedt, BK; Sauer, BG; Lennon, AM (April 2018). "ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts". The American Journal of Gastroenterology. 113 (4): 464–479. doi:10.1038/ajg.2018.14. PMID 29485131. S2CID 3584079.
Farrell JJ, Fernández-del Castillo C (June 2013). "Pancreatic cystic neoplasms: management and unanswered questions". Gastroenterology. 144 (6): 1303–15. doi:10.1053/j.gastro.2013.01.073. PMID 23622140.
The PanNET denomination is in line with WHO guidelines for the classification of tumors of the digestive system "WHO classification of tumours of the digestive system – NLM Catalog – NCBI". Archived from the original on 9 September 2017. Retrieved 7 September 2017. published in 2010. Historically, PanNETs have also been referred to by a variety of terms, and are still commonly called "pancreatic endocrine tumors". See: Klimstra DS, Modlin IR, Coppola D, Lloyd RV, Suster S (August 2010). "The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems". Pancreas. 39 (6): 707–12. doi:10.1097/MPA.0b013e3181ec124e. PMID 20664470. S2CID 3735444.
Burns WR, Edil BH (March 2012). "Neuroendocrine pancreatic tumors: guidelines for management and update". Current Treatment Options in Oncology. 13 (1): 24–34. doi:10.1007/s11864-011-0172-2. PMID 22198808. S2CID 7329783.
Furukawa H, Okada S, Saisho H, Ariyama J, Karasawa E, Nakaizumi A, Nakazawa S, Murakami K, Kakizoe T (1996). "Clinicopathologic features of small pancreatic adenocarcinoma. A collective study". Cancer. 1, 78 (5): 986–990. doi:10.1002/(SICI)1097-0142(19960901)78:5<986::AID-CNCR7>3.0.CO;2-A. PMID 8780535. Retrieved 7 May 2024.{{cite journal}}: نگهداری CS1: نقطه‌گذاری اضافه (link)
De La Cruz MS, Young AP, Ruffin MT (April 2014). "Diagnosis and management of pancreatic cancer". American Family Physician. 89 (8): 626–32. PMID 24784121.
Khorana, Alok A; Fine, Robert L. (2004). "Pancreatic cancer and thromboembolic disease". The Lancet Oncology. 5 (11): 655–663. doi:10.1016/S1470-2045(04)01606-7. PMID 15522652. Retrieved 8 May 2024.
Tsuchiya R, Noda T, Harada N, Miyamoto T, Tomioka T, Yamamoto K, Yamaguchi T, Izawa K, Tsunoda T, Yoshino R (1986). "Collective review of small carcinomas of the pancreas". Annals of Surgical Oncology. 203 (1). doi:10.1097/00000658-198601000-00013. PMC 1251042. PMID 3942423. Retrieved 7 May 2024.{{cite journal}}: نگهداری CS1: نقطه‌گذاری اضافه (link) نگهداری یادکرد:فرمت پارامتر PMC (link)
Kalser, Martin H.; Barkin, Jamie; Macintyre, John M. (1985). "Pancreatic cancer. Assessment of prognosis by clinical presentation". Cancer. 56 (2): 397–402. doi:10.1002/1097-0142(19850715)56:2<397::aid-cncr2820560232>3.0.co;2-i. PMID 4005804. Retrieved 8 May 2024.
Manabe T, Miyashita T, Ohshio G, Nonaka A, Suzuki T, Endo K, Takahashi M, Tobe T (1988). "Small carcinoma of the pancreas. Clinical and pathologic evaluation of 17 patients". cancer. 62 (1): 135–141. doi:10.1002/1097-0142(19880701)62:1<135::aid-cncr2820620123>3.0.co;2-t. PMID 3164230. Retrieved 8 May 2024.
Sun, L.; Quan, X.Q.; Yu, S. (2015). "An Epidemiological Survey of Cachexia in Advanced Cancer Patients and Analysis on Its Diagnostic and Treatment Status". Nutr Cancer. 67 (7): 1056–1062. doi:10.1080/01635581.2015.1073753. PMID 26317149.
Tan, C.R.; Yaffee, P.M.; Jamil, L.H.; Lo, S.K.; Nissen, N. (2014). "Pancreatic cancer cachexia: a review of mechanisms and therapeutics". Front Physiol. 5: 88. doi:10.3389/fphys.2014.00088. PMID 24624094.
Mueller, T.C.; Burmeister, M.A.; Bachmann, J.; Martignoni, M.E. (2014). "Cachexia and pancreatic cancer: are there treatment options?". World J Gastroenterol. 20 (28): 9361–9373. doi:10.3748/wjg.v20.i28.9361. PMID 25071331.
Pannala R, Basu A, Petersen GM, Chari ST (January 2009). "New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer". The Lancet. Oncology. 10 (1): 88–95. doi:10.1016/S1470-2045(08)70337-1. PMC 2795483. PMID 19111249.
Porta M, Fabregat X, Malats N, Guarner L, Carrato A, de Miguel A, Ruiz L, Jariod M, Costafreda S, Coll S, Alguacil J, Corominas JM, Sola R, Salas A, Real FX (2005). "Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage". Clinical and Translational Oncology. 7 (5): 189–197. doi:10.1007/BF02712816. Retrieved 7 May 2024.
Pinzon R, Drewinko B, Trujillo JM, Guinee V, Giacco G (1986). "Pancreatic carcinoma and Trousseau's syndrome: experience at a large cancer center". Journal of Clinical Oncology. 4 (4). doi:10.1200/JCO.1986.4.4.509. PMID 3958764. Retrieved 8 May 2024.
Jia, L.; Jiang, S.M.; Shang, Y.Y.; Huang, Y.X.; Li, Y.J. (2010). "Investigation of the incidence of pancreatic cancer-related depression and its relationship with the quality of life of patients". Digestion. 82 (1): 4–9. doi:10.1159/000253864. PMID 20145402.
Mayr, M.; Schmid, R.M. (2010). "Pancreatic cancer and depression: myth and truth". BMC Cancer. 10: 569. doi:10.1186/1471-2407-10-569. PMID 20961421.
Breitbart, W.; Rosenfeld, B.; Tobias, K.; Pessin, H.; Ku, G.Y. (2014). "Depression, cytokines, and pancreatic cancer". Psychooncology. 23 (3): 339–345. doi:10.1002/pon.3422. PMID 24136882.
Ostlere, Lucy S.; Branfoot, Anthony C.; Staughton, Richard Charles D. (1992). "Cicatricial pemphigoid and carcinoma of the pancreas". Clinical and Experimental Dermatology. 17 (1): 67–68. doi:10.1111/j.1365-2230.1992.tb02541.x. PMID 1330387. Retrieved 8 May 2024.
Batabyal, P.; Vander Hoorn, S.; Christophi, C.; Nikfarjam, M. (2014). "Association of diabetes mellitus and pancreatic adenocarcinoma: a meta-analysis of 88 studies". Ann Surg Oncol. 21 (7): 2453–2462. doi:10.1245/s10434-014-3625-6. PMID 24609291.
Sperti C, Moletta L, Patanè G (October 2014). "Metastatic tumors to the pancreas: The role of surgery". World Journal of Gastrointestinal Oncology. 6 (10): 381–92. doi:10.4251/wjgo.v6.i10.381. PMC 4197429. PMID 25320654.
Lowenfels, A.B.; Maisonneuve, P. (2004). "Epidemiology and prevention of pancreatic cancer". Jpn J Clin Oncol. 34 (5): 238–244. PMID 15231857. Archived from the original on 9 July 2011. Retrieved 16 May 2024.{{cite journal}}: نگهداری یادکرد:ربات:وضعیت نامعلوم پیوند اصلی (link)
Bosetti C, Lucenteforte E, Silverman DT, Petersen G, Bracci PM, Ji BT, et al. (July 2012). "Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4)". Annals of Oncology. 23 (7): 1880–88. doi:10.1093/annonc/mdr541. PMC 3387822. PMID 22104574.
Yadav, D.; Lowenfels, A.B. (2013). "The epidemiology of pancreatitis and pancreatic cancer". Gastroenterology. 144 (6): 1252–1261. doi:10.1053/j.gastro.2013.01.068. PMID 23622135.
Berger, N.A. (2014). "Obesity and cancer pathogenesis". Ann N Y Acad Sci. 1311: 57–76. doi:10.1111/nyas.12416. PMID 24725147.
Stolzenberg-Solomon, R.Z.; Pietinen, P.; Taylor, P.R.; Virtamo, J.; Albanes, D. (2002). "Prospective study of diet and pancreatic cancer in male smokers". Am J Epidemiol. 155 (9): 783–792. PMID 11978580.
Ghadirian, P.; Simard, A.; Baillargeon, J.; Maisonneuve, P.; Boyle, P. (1991). "Nutritional factors and pancreatic cancer in the francophone community in Montréal, Canada". Int J Cancer. 47 (1): 1–6. PMID 1845960.
Chan, J.M.; Wang, F.; Holly, E.A. (2007). "Pancreatic cancer, animal protein and dietary fat in a population-based study, San Francisco Bay Area, California". Cancer Causes Control. 18 (10): 1153–1167. doi:10.1007/s10552-007-9054-0. PMID 17805983.
Zhang, J.; Dhakal, I.B.; Gross, M.D.; Lang, N.P.; Kadlubar, F.F. (2009). "Physical activity, diet, and pancreatic cancer: a population-based, case-control study in Minnesota". Nutr Cancer. 61 (4): 457–465. doi:10.1080/01635580902718941. PMID 19838917.
Rohrmann, Sabine; et al. (2013). "Meat and fish consumption and risk of pancreatic cancer: Results from the European Prospective Investigation into Cancer and Nutrition". International Journal of Cancer. 132 (3): 617–624. doi:10.1002/ijc.27637. PMID 22610753. S2CID 2613568.
Olson, S.H.; Kurtz, R.C. (2013). "Epidemiology of pancreatic cancer and the role of family history". J Surg Oncol. 107 (1): 1–7. doi:10.1002/jso.23149. PMID 22589078.
Herreros-Villanueva, M.; Hijona, E.; Bañales, J.M.; Cosme, A.; Bujanda, L. (2013). "Alcohol consumption on pancreatic diseases". World J Gastroenterol. 19 (5): 638–647. doi:10.3748/wjg.v19.i5.638. PMID 23429423.
Kloner, Robert A.; Rezkalla, Shereif H. (2007). "To drink or not to drink? That is the question". Circulation. 116 (11): 1306–1317. doi:10.1161/CIRCULATIONAHA.106.678375. PMID 17846344. Retrieved 2 January 2025.
Kerr, William C; Greenfield, Thomas K; Tujague, Jennifer; Brown, Stephan E (2005). "A drink is a drink? Variation in the amount of alcohol contained in beer, wine and spirits drinks in a US methodological sample". Alcoholism: Clinical and Experimental Research. 29 (11): 2015–2021. doi:10.1097/01.alc.0000187596.92804.bd. PMID 16340459. Retrieved 2 January 2025.
Pericleous M, Rossi RE, Mandair D, Whyand T, Caplin ME (January 2014). "Nutrition and pancreatic cancer". Anticancer Research. 34 (1): 9–21. PMID 24403441.
Genkinger, J.M.; Spiegelman, D.; Anderson, K.E.; Bergkvist, L.; Bernstein, L. (2009). "Alcohol intake and pancreatic cancer risk: a pooled analysis of fourteen cohort studies". Cancer Epidemiol Biomarkers Prev. 18 (3): 765–776. doi:10.1158/1055-9965.EPI-08-0880. PMID 19258474.
Lucenteforte, E.; La Vecchia, C.; Silverman, D.; Petersen, G.M.; Bracci, P.M. (2012). "Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4)". Ann Oncol. 23 (2): 374–382. doi:10.1093/annonc/mdr120. PMID 21536662.
Tramacere, I.; Scotti, L.; Jenab, M.; Bagnardi, V.; Bellocco, R. (2010). "Alcohol drinking and pancreatic cancer risk: a meta-analysis of the dose-risk relation". Int J Cancer. 126 (6): 1474–1486. doi:10.1002/ijc.24936. PMID 19816941.
Peters ML, Tseng JF, Miksad RA (July 2016). "Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment". Clinical Therapeutics. 38 (7): 1622–35. doi:10.1016/j.clinthera.2016.03.006. PMID 27041411.
Tersmette, A.C.; Petersen, G.M.; Offerhaus, G.J.; Falatko, F.C.; Brune, K.A. (2001). "Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer". Clin Cancer Res. 7 (3): 738–744. PMID 11297271.
Rustgi, A.K. (2014). "Familial pancreatic cancer: genetic advances". Genes Dev. 28 (1): 1–7. doi:10.1101/gad.228452.113. PMID 24395243.
Korsse, S.E.; Harinck, F.; van Lier, M.G.; Biermann, K.; Offerhaus, G.J. (2013). "Pancreatic cancer risk in Peutz-Jeghers syndrome patients: a large cohort study and implications for surveillance". J Med Genet. 50 (1): 59–64. doi:10.1136/jmedgenet-2012-101277. PMID 23240097.
Hsu FC, Roberts NJ, Childs E, Porter N, Rabe KG, Borgida A, Ukaegbu C, Goggins MG, Hruban RH, Zogopoulos G, Syngal S, Gallinger S, Petersen GM, Klein AP (2021). "Risk of Pancreatic Cancer Among Individuals With Pathogenic Variants in the ATM Gene". JAMA Oncol. 7 (11): 1664–1668. doi:10.1001/jamaoncol.2021.3701. PMC 8446906. PMID 34529012. Retrieved 17 May 2024.
Hannan Z, Yu S, Domchek S, Mamtani R, Reiss KA (2021). "Clinical Characteristics of Patients With Pancreatic Cancer and Pathogenic ATM Alterations". JNCI Cancer Spectr. 5 (2): 1–4. doi:10.1093/jncics/pkaa121. PMC 7952223. PMID 33733050. Retrieved 17 May 2024.
Easton, D.; Thompson, D.; McGuffog, L.; Haites, N.; Schofield, A. (1999). "Cancer risks in BRCA2 mutation carriers". J Natl Cancer Inst. 91 (15): 1310–1316. PMID 10433620.
Grover, S.; Syngal, S. (2010). "Hereditary pancreatic cancer". Gastroenterology. 139 (4): 1076–1080, 1080.e1-2. doi:10.1053/j.gastro.2010.08.012. PMID 20727885.
Geary, J.; Sasieni, P.; Houlston, R.; Izatt, L.; Eeles, R. (2008). "Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC)". Fam Cancer. 7 (2): 163–172. doi:10.1007/s10689-007-9164-6. PMID 17939062.
Giardiello, F.M.; Offerhaus, G.J.; Lee, D.H.; Krush, A.J.; Tersmette, A.C. (1993). "Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis". Gut. 34 (10): 1394–1396. PMID 8244108.
Maire, F.; Hammel, P.; Terris, B.; Olschwang, S.; O’Toole, D. (2002). "Intraductal papillary and mucinous pancreatic tumour: a new extracolonic tumour in familial adenomatous polyposis". Gut. 51 (3): 446–449. PMID 12171972.
Raimondi, S.; Lowenfels, A.B.; Morselli-Labate, A.M.; Maisonneuve, P.; Pezzilli, R. (2010). "Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection". Best Pract Res Clin Gastroenterol. 24 (3): 349–358. doi:10.1016/j.bpg.2010.02.007. PMID 20510834.
Becker, A.E.; Hernandez, Y.G.; Frucht, H.; Lucas, A.L. (2014). "Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection". World J Gastroenterol. 20 (32): 11182–11198. doi:10.3748/wjg.v20.i32.11182. PMID 25170203.
Reznik R, Hendifar AE, Tuli R (2014). "Genetic determinants and potential therapeutic targets for pancreatic adenocarcinoma". Frontiers in Physiology. 5: 87. doi:10.3389/fphys.2014.00087. PMC 3939680. PMID 24624093.
Lowenfels, A.B.; Maisonneuve, P.; DiMagno, E.P.; Elitsur, Y.; Gates, L.K. (1997). "Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group". J Natl Cancer Inst. 89 (6): 442–446. PMID 9091646.
Howes, N.; Lerch, M.M.; Greenhalf, W.; Stocken, D.D.; Ellis, I. (2004). "Clinical and genetic characteristics of hereditary pancreatitis in Europe". Clin Gastroenterol Hepatol. 2 (3): 252–261. PMID 15017610.
Paliwal, S.; Bhaskar, S.; Chandak, G.R. (2014). "Genetic and phenotypic heterogeneity in tropical calcific pancreatitis". World J Gastroenterol. 20 (46): 17314–17323. doi:10.3748/wjg.v20.i46.17314. PMID 25516642.
Everhart, J.; Wright, D. "Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis". JAMA. 273 (20): 1605–1609. PMID 7745774.
Huxley, R.; Ansary-Moghaddam, A.; Berrington de González, A.; Barzi, F.; Woodward, M. (2005). "Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies". Br J Cancer. 92 (11): 2076–2083. doi:10.1038/sj.bjc.6602619. PMID 15886696.
Li, D.; Tang, H.; Hassan, M.M.; Holly, E.A.; Bracci, P.M. (2011). "Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies". Cancer Causes Control. 22 (2): 189–197. doi:10.1007/s10552-010-9686-3. PMID 21104117.
Hagymási, K.; Tulassay, Z. (2014). "Helicobacter pylori infection: new pathogenetic and clinical aspects". World J Gastroenterol. 20 (21): 6386–6399. doi:10.3748/wjg.v20.i21.6386. PMID 24914360.
Bulajic, M.; Panic, N.; Löhr, J.M. (2014). "Helicobacter pylori and pancreatic diseases". World J Gastrointest Pathophysiol. 5 (4): 380–383. doi:10.4291/wjgp.v5.i4.380. PMID 25400980.
Michaud, D.S. (2013). "Role of bacterial infections in pancreatic cancer". Carcinogenesis. 34 (10): 2193–2197. doi:10.1093/carcin/bgt249. PMID 23843038.
Risch, H.A.; Lu, L.; Wang, J.; Zhang, W.; Ni, Q. (2013). "ABO blood group and risk of pancreatic cancer: a study in Shanghai and meta-analysis". Am J Epidemiol. 177 (12): 1326–1337. doi:10.1093/aje/kws458. PMID 23652164.
Zhang, B.L.; He, N.; Huang, Y.B.; Song, F.J.; Chen, K.X. (2014). "ABO blood groups and risk of cancer: a systematic review and meta-analysis". Asian Pac J Cancer Prev. 15 (11): 4643–4650. PMID 24969898.
Egawa, N.; Lin, Y.; Tabata, T.; Kuruma, S.; Hara, S. (2013). "ABO blood type, long-standing diabetes, and the risk of pancreatic cancer". World J Gastroenterol. 19 (16): 2537–2542. doi:10.3748/wjg.v19.i16.2537. PMID 23674856.
Engin, H.; Bilir, C.; Üstün, H.; Gökmen, A. (2012). "ABO blood group and risk of pancreatic cancer in a Turkish population in Western Blacksea region". Asian Pac J Cancer Prev. 13 (1): 131–133. PMID 22502655.
Karoumpalis, Ioannis; Christodoulou, Dimitrios K (2016). "Cystic lesions of the pancreas". Annals of Gastroenterology. 29 (2): 155–161. doi:10.20524/aog.2016.0007. PMID 27065727. Retrieved 2 January 2025.
Hackeng WM, Hruban RH, Offerhaus GJ, Brosens LA (2016). "Surgical and molecular pathology of pancreatic neoplasms". Diagn Pathol. 11 (1): 47. doi:10.1186/s13000-016-0497-z. PMC 4897815. PMID 27267993.{{cite journal}}: نگهداری یادکرد:نام‌های متعدد:فهرست نویسندگان (link) (distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/)), Image title and optimization: Mikael Häggström, M.D.
Delpu Y, Hanoun N, Lulka H, Sicard F, Selves J, Buscail L, et al. (March 2011). "Genetic and epigenetic alterations in pancreatic carcinogenesis". Current Genomics. 12 (1): 15–24. doi:10.2174/138920211794520132. PMC 3129039. PMID 21886451.
Rooney SL, Shi J (October 2016). "Intraductal Tubulopapillary Neoplasm of the Pancreas: An Update From a Pathologist's Perspective". Archives of Pathology & Laboratory Medicine. 140 (10): 1068–73. doi:10.5858/arpa.2016-0207-RA. PMID 27684978.
Uhlen M, Zhang C, Lee S, Sjöstedt E, Fagerberg L, Bidkhori G, et al. (August 2017). "A pathology atlas of the human cancer transcriptome". Science. 357 (6352): eaan2507. doi:10.1126/science.aan2507. PMID 28818916.
Lewis MA, Yao JC (February 2014). "Molecular pathology and genetics of gastrointestinal neuroendocrine tumours". Current Opinion in Endocrinology, Diabetes and Obesity. 21 (1): 22–27. doi:10.1097/MED.0000000000000033. PMID 24310147. S2CID 31094880.
Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, et al. (September 2012). "Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)". The Journal of Clinical Endocrinology and Metabolism. 97 (9): 2990–3011. doi:10.1210/jc.2012-1230. PMID 22723327.
Artinyan, A.; Soriano, P.A.; Prendergast, C.; Low, T.; Ellenhorn, J.D. (2008). "The anatomic location of pancreatic cancer is a prognostic factor for survival". HPB (Oxford). 10 (5): 371–376. doi:10.1080/13651820802291233. PMID 18982154.
Fitzgerald JE, White MJ, Lobo DN (April 2009). "Courvoisier's gallbladder: law or sign?". World Journal of Surgery. 33 (4): 886–91. doi:10.1007/s00268-008-9908-y. PMID 19190960. S2CID 21799234.
Skafida E, Grammatoglou X, Glava C, Zissis D, Paschalidis N, Katsamagkou E, et al. (February 2010). "Adenosquamous carcinoma of the pancreas: a case report". Cases Journal. 3 (1): 41. doi:10.1186/1757-1626-3-41. PMC 2825199. PMID 20205828.
Adsay V, Mino-Kenudson M, Furukawa T, Basturk O, Zamboni G, Marchegiani G, et al. (January 2016). "Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting". Annals of Surgery. 263 (1): 162–77. doi:10.1097/SLA.0000000000001173. PMC 4568174. PMID 25775066.
Cascinu S, Falconi M, Valentini V, Jelic S (May 2010). "Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up". Annals of Oncology. 21 Suppl 5 (Supplement 5): v55–58. doi:10.1093/annonc/mdq165. PMID 20555103.
Isaji S, Kawarada Y (2000). "[Evaluation of classification of pancreatic cancer by the Japan Pancreas Society and Union Internationale Contre le Cancer and proposal for a new international classification]". Nihon Geka Gakkai Zasshi (به ژاپنی). 101 (2): 205–11. PMID 10734638.
Kobari M, Matsuno S (1998). "Staging systems for pancreatic cancer: differences between the Japanese and UICC systems". J Hepatobiliary Pancreat Surg. 5 (2): 121–7. PMID 9745076. Archived from the original on 18 May 2024.
Michaud, D.S.; Giovannucci, E.; Willett, W.C.; Colditz, G.A.; Stampfer, M.J. "Physical activity, obesity, height, and the risk of pancreatic cancer". JAMA. 286 (8): 921–929. PMID 11509056.
Gold, E.B.; Gordis, L.; Diener, M.D.; Seltser, R.; Boitnott, J.K. (1985). "Diet and other risk factors for cancer of the pancreas". Cancer. 55 (2): 460–467. PMID 3965101.
Bueno de Mesquita, H.B.; Maisonneuve, P.; Runia, S.; Moerman, C.J. (1991). "Intake of foods and nutrients and cancer of the exocrine pancreas: a population-based case-control study in The Netherlands". Int J Cancer. 48 (4): 540–549. PMID 1646177.
Chan, J.M.; Wang, F.; Holly, E.A. (2005). "Vegetable and fruit intake and pancreatic cancer in a population-based case-control study in the San Francisco bay area". Cancer Epidemiol Biomarkers Prev. 14 (9): 2093–2097. doi:10.1158/1055-9965.EPI-05-0226. PMID 16172215.
Chan, J.M.; Wang, F.; Holly, E.A. (2007). "Whole grains and risk of pancreatic cancer in a large population-based case-control study in the San Francisco Bay Area, California". Am J Epidemiol. 166 (10): 1174–1185. doi:10.1093/aje/kwm194. PMID 17881383.
Howe, G.R.; Ghadirian, P.; Bueno de Mesquita, H.B.; Zatonski, W.A.; Baghurst, P.A. (1992). "A collaborative case-control study of nutrient intake and pancreatic cancer within the search programme". Int J Cancer. 51 (3): 365–372. PMID 1317361.
Howe, G.R.; Jain, M.; Miller, A.B. (1990). "Dietary factors and risk of pancreatic cancer: results of a Canadian population-based case-control study". Int J Cancer. 45 (4): 604–608. PMID 2157670.
Sun, J.; Li, Y.; Liu, L.; Jiang, Z.; Liu, G. (2019). "Aspirin use and pancreatic cancer risk: A systematic review of observational studies - PubMed". Medicine. 98 (51): e18033. doi:10.1097/MD.0000000000018033. PMC 6940047. PMID 31860953.
Currie, C.J.; Poole, C.D.; Gale, E.A. (2009). "The influence of glucose-lowering therapies on cancer risk in type 2 diabetes". Diabetologia. 52 (9): 1766–1777. doi:10.1007/s00125-009-1440-6. PMID 19572116.
Li, D.; Yeung, S.C.; Hassan, M.M.; Konopleva, M.; Abbruzzese, J.L. (2009). "Antidiabetic therapies affect risk of pancreatic cancer". Gastroenterology. 137 (2): 482–488. doi:10.1053/j.gastro.2009.04.013. PMID 19375425.
Decensi, A.; Puntoni, M.; Goodwin, P.; Cazzaniga, M.; Gennari, A. (2010). "Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis". Cancer Prev Res (Phila). 3 (11): 1451–1461. doi:10.1158/1940-6207.CAPR-10-0157. PMID 20947488.
Li, D. (2012). "Diabetes and pancreatic cancer". Mol Carcinog. 51 (1): 64–74. doi:10.1002/mc.20771. PMID 22162232.
Monami, M.; Lamanna, C.; Balzi, D.; Marchionni, N.; Mannucci, E. (2009). "Sulphonylureas and cancer: a case-control study". Acta Diabetol. 46 (4): 279–284. doi:10.1007/s00592-008-0083-2. PMID 19082520.
He XY, Yuan YZ (August 2014). "Advances in pancreatic cancer research: moving towards early detection". World Journal of Gastroenterology. 20 (32): 11241–48. doi:10.3748/wjg.v20.i32.11241. PMC 4145762. PMID 25170208.
Okano K, Suzuki Y (August 2014). "Strategies for early detection of resectable pancreatic cancer". World Journal of Gastroenterology. 20 (32): 11230–40. doi:10.3748/wjg.v20.i32.11230. PMC 4145761. PMID 25170207.
Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, et al. (August 2019). "Screening for Pancreatic Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement". JAMA. 322 (5): 438–44. doi:10.1001/jama.2019.10232. PMID 31386141.
Seufferlein T, Bachet JB, Van Cutsem E, Rougier P (October 2012). "Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up". Annals of Oncology. 23 (Suppl 7): vii33–40. doi:10.1093/annonc/mds224. PMID 22997452.
Goggins M, Overbeek KA, Brand R, Syngal S, Del Chiaro M, Bartsch DK, et al. (January 2020). "Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium". Gut. 69 (1): 7–17. doi:10.1136/gutjnl-2019-319352. PMC 7295005. PMID 31672839.
Jansen, R.J.; Tan, X.L.; Petersen, G.M. (2015). "Gene-by-Environment Interactions in Pancreatic Cancer: Implications for Prevention". Yale J Biol Med. 88 (2): 115–126. PMID 26029010.
Gurusamy KS, Kumar S, Davidson BR, Fusai G (February 2014). "Resection versus other treatments for locally advanced pancreatic cancer". The Cochrane Database of Systematic Reviews. 2 (2): CD010244. doi:10.1002/14651858.CD010244.pub2. PMID 24578248.
Mollberg N, Rahbari NN, Koch M, Hartwig W, Hoeger Y, Büchler MW, Weitz J (December 2011). "Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis". Annals of Surgery. 254 (6): 882–93. doi:10.1097/SLA.0b013e31823ac299. PMID 22064622. S2CID 42685174.
Heinemann V, Haas M, Boeck S (October 2013). "Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancer". Annals of Oncology. 24 (10): 2484–92. doi:10.1093/annonc/mdt239. PMID 23852311.
Thota R, Pauff JM, Berlin JD (January 2014). "Treatment of metastatic pancreatic adenocarcinoma: a review". Oncology. 28 (1): 70–74. PMID 24683721.
Conroy, T; Desseigne, F; Ychou, M; et al, on behalf of Groupe Tumeurs Digestives of Unicancer, PRODIGE Intergroup (2011). "FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer". New England Journal of Medicine. 364 (19): 1817–1825. doi:10.1056/nejmoa1011923. PMID 21561347.{{cite journal}}: نگهداری یادکرد:نام‌های متعدد:فهرست نویسندگان (link)
Borazanci E, Von Hoff DD (September 2014). "Nab-paclitaxel and gemcitabine for the treatment of patients with metastatic pancreatic cancer". Expert Review of Gastroenterology & Hepatology. 8 (7): 739–47. doi:10.1586/17474124.2014.925799. PMID 24882381. S2CID 31633898.
Neoptolemos, Jp; Dunn, Ja; Stocken, Dd; Almond, J; Link, K; Beger, H; Bassi, C; Falconi, M; Pederzoli, P; Dervenis, C; Fernandez-Cruz, L (November 2001). "Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial". The Lancet (به انگلیسی). 358 (9293): 1576–1585. doi:10.1016/S0140-6736(01)06651-X. PMID 11716884. S2CID 23803289.
Neoptolemos, John P.; Stocken, Deborah D.; Friess, Helmut; Bassi, Claudio; Dunn, Janet A.; Hickey, Helen; Beger, Hans; Fernandez-Cruz, Laureano; Dervenis, Christos; Lacaine, François; Falconi, Massimo (2004-03-18). "A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer". New England Journal of Medicine (به انگلیسی). 350 (12): 1200–1210. doi:10.1056/NEJMoa032295. ISSN 0028-4793. PMID 15028824.
Falconi M, Bartsch DK, Eriksson B, Klöppel G, Lopes JM, O'Connor JM, et al. (2012). "ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors". Neuroendocrinology. 95 (2): 120–34. doi:10.1159/000335587. PMID 22261872. S2CID 6985904.
Jensen RT, Cadiot G, Brandi ML, de Herder WW, Kaltsas G, Komminoth P, et al. (2012). "ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes". Neuroendocrinology. 95 (2): 98–119. doi:10.1159/000335591. PMC 3701449. PMID 22261919.
Pavel M, Baudin E, Couvelard A, Krenning E, Öberg K, Steinmüller T, et al. (2012). "ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary". Neuroendocrinology. 95 (2): 157–76. doi:10.1159/000335597. PMID 22262022. S2CID 2097604.
Rossi RE, Massironi S, Conte D, Peracchi M (January 2014). "Therapy for metastatic pancreatic neuroendocrine tumors". Annals of Translational Medicine. 2 (1): 8. doi:10.3978/j.issn.2305-5839.2013.03.01. PMC 4200651. PMID 25332984.
Gulenchyn KY, Yao X, Asa SL, Singh S, Law C (May 2012). "Radionuclide therapy in neuroendocrine tumours: a systematic review". Clinical Oncology. 24 (4): 294–308. doi:10.1016/j.clon.2011.12.003. PMID 22221516.
Vinik AI (November 2014). "Advances in diagnosis and treatment of pancreatic neuroendocrine tumors". Endocrine Practice. 20 (11): 1222–30. doi:10.4158/EP14373.RA. PMID 25297671.
Kwekkeboom DJ, de Herder WW, van Eijck CH, Kam BL, van Essen M, Teunissen JJ, Krenning EP (March 2010). "Peptide receptor radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumors". Seminars in Nuclear Medicine. 40 (2): 78–88. doi:10.1053/j.semnuclmed.2009.10.004. PMID 20113677.
Bodei L, Cremonesi M, Kidd M, Grana CM, Severi S, Modlin IM, Paganelli G (August 2014). "Peptide receptor radionuclide therapy for advanced neuroendocrine tumors". Thoracic Surgery Clinics. 24 (3): 333–49. doi:10.1016/j.thorsurg.2014.04.005. hdl:11392/2378236. PMID 25065935.
Castellano D, Grande E, Valle J, Capdevila J, Reidy-Lagunes D, O'Connor JM, Raymond E (June 2015). "Expert consensus for the management of advanced or metastatic pancreatic neuroendocrine and carcinoid tumors". Cancer Chemotherapy and Pharmacology. 75 (6): 1099–114. doi:10.1007/s00280-014-2642-2. PMID 25480314. S2CID 39434924.
Singh S, Dey C, Kennecke H, Kocha W, Maroun J, Metrakos P, et al. (August 2015). "Consensus Recommendations for the Diagnosis and Management of Pancreatic Neuroendocrine Tumors: Guidelines from a Canadian National Expert Group". Annals of Surgical Oncology. 22 (8): 2685–99. doi:10.1245/s10434-014-4145-0. PMID 25366583. S2CID 8129133.
Buanes TA (August 2014). "Pancreatic cancer-improved care achievable". World Journal of Gastroenterology. 20 (30): 10405–18. doi:10.3748/wjg.v20.i30.10405. PMC 4130847. PMID 25132756.
Bilimoria, K.Y.; Bentrem, D.J.; Ko, C.Y.; Ritchey, J.; Stewart, A.K. (2007). "Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database". Cancer. 110 (4): 738–744. doi:10.1002/cncr.22852. PMID 17580363.
Sun, H.; Ma, H.; Hong, G.; Sun, H.; Wang, J. (2014). "Survival improvement in patients with pancreatic cancer by decade: a period analysis of the SEER database, 1981–2010". Sci Rep. 4: 6747. doi:10.1038/srep06747. PMID 25339498.
Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007). "Cancer statistics, 2007". CA: A Cancer Journal for Clinicians. 57 (1): 43–66. doi:10.3322/canjclin.57.1.43. PMID 17237035. S2CID 22305510.
Busnardo AC, DiDio LJ, Tidrick RT, Thomford NR (November 1983). "History of the pancreas". American Journal of Surgery. 146 (5): 539–50. doi:10.1016/0002-9610(83)90286-6. PMID 6356946.
Are C, Dhir M, Ravipati L (June 2011). "History of pancreaticoduodenectomy: early misconceptions, initial milestones and the pioneers". HPB. 13 (6): 377–84. doi:10.1111/j.1477-2574.2011.00305.x. PMC 3103093. PMID 21609369.
Cameron JL, Riall TS, Coleman J, Belcher KA (July 2006). "One thousand consecutive pancreaticoduodenectomies". Annals of Surgery. 244 (1): 10–5. doi:10.1097/01.sla.0000217673.04165.ea. PMC 1570590. PMID 16794383.
Fernández-del Castillo C, Morales-Oyarvide V, McGrath D, Wargo JA, Ferrone CR, Thayer SP, et al. (September 2012). "Evolution of the Whipple procedure at the Massachusetts General Hospital". Surgery. 152 (3 Suppl 1): S56-63. doi:10.1016/j.surg.2012.05.022. PMC 3806095. PMID 22770961.
Reznik R, Hendifar AE, Tuli R (2014). "Genetic determinants and potential therapeutic targets for pancreatic adenocarcinoma". Frontiers in Physiology. 5: 87. doi:10.3389/fphys.2014.00087. PMC 3939680. PMID 24624093.
Biankin AV, Waddell N, Kassahn KS, Gingras MC, Muthuswamy LB, Johns AL, et al. (November 2012). "Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes". Nature. 491 (7424): 399–405. Bibcode:2012Natur.491..399.. doi:10.1038/nature11547. PMC 3530898. PMID 23103869.
Feng, Hui-Yi; Chen, Yang-Chao (2016-09-07). "Role of bile acids in carcinogenesis of pancreatic cancer: An old topic with new perspective". World Journal of Gastroenterology. 22 (33): 7463–7477. doi:10.3748/wjg.v22.i33.7463. ISSN 1007-9327. PMC 5011662. PMID 27672269.
Graham JS, Jamieson NB, Rulach R, Grimmond SM, Chang DK, Biankin AV (September 2015). "Pancreatic cancer genomics: where can the science take us?". Clinical Genetics. 88 (3): 213–9. doi:10.1111/cge.12536. PMID 25388820. S2CID 26414866.
Bruenderman EH, Martin RC (March 2015). "High-risk population in sporadic pancreatic adenocarcinoma: guidelines for screening". The Journal of Surgical Research. 194 (1): 212–9. doi:10.1016/j.jss.2014.06.046. PMC 4559279. PMID 25479908.
Subar D, Gobardhan PD, Gayet B (February 2014). "Laparoscopic pancreatic surgery: An overview of the literature and experiences of a single center". Best Practice & Research. Clinical Gastroenterology. 28 (1): 123–32. doi:10.1016/j.bpg.2013.11.011. PMID 24485260.
Weiss MJ, Wolfgang CL (2013). "Irreversible electroporation: a novel pancreatic cancer therapy". Current Problems in Cancer. 37 (5): 262–5. doi:10.1016/j.currproblcancer.2013.10.002. PMID 24331180. S2CID 3137300.
Moir J, White SA, French JJ, Littler P, Manas DM (December 2014). "Systematic review of irreversible electroporation in the treatment of advanced pancreatic cancer". European Journal of Surgical Oncology. 40 (12): 1598–604. doi:10.1016/j.ejso.2014.08.480. PMID 25307210.
Kleger A, Perkhofer L, Seufferlein T (July 2014). "Smarter drugs emerging in pancreatic cancer therapy". Annals of Oncology. 25 (7): 1260–1270. doi:10.1093/annonc/mdu013. PMID 24631947.
Tang SC, Chen YC (اوت 2014). "Novel therapeutic targets for pancreatic cancer". World Journal of Gastroenterology. 20 (31): 10825–44. doi:10.3748/wjg.v20.i31.10825. PMC 4138462. PMID 25152585.
Tanase CP, Neagu AI, Necula LG, Mambet C, Enciu AM, Calenic B, et al. (August 2014). "Cancer stem cells: involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics". World Journal of Gastroenterology. 20 (31): 10790–801. doi:10.3748/wjg.v20.i31.10790. PMC 4138459. PMID 25152582.
Tang SC, Chen YC (اوت 2014). "Novel therapeutic targets for pancreatic cancer". World Journal of Gastroenterology. 20 (31): 10825–44. doi:10.3748/wjg.v20.i31.10825. PMC 4138462. PMID 25152585.
Rossi ML, Rehman AA, Gondi CS (August 2014). "Therapeutic options for the management of pancreatic cancer". World Journal of Gastroenterology. 20 (32): 11142–59. doi:10.3748/wjg.v20.i32.11142. PMC 4145755. PMID 25170201.
Ady JW, Heffner J, Klein E, Fong Y (2014). "Oncolytic viral therapy for pancreatic cancer: current research and future directions". Oncolytic Virotherapy. 3: 35–46. doi:10.2147/OV.S53858. PMC 4918362. PMID 27512661.
Ren B, Cui M, Yang G, Wang H, Feng M, You L, Zhao Y (July 2018). "Tumor microenvironment participates in metastasis of pancreatic cancer". Molecular Cancer. 17 (1): 108. doi:10.1186/s12943-018-0858-1. PMC 6065152. PMID 30060755.

ncbi.nlm.nih.gov

Wolfgang CL, Herman JM, Laheru DA, Klein AP, Erdek MA, Fishman EK, Hruban RH (September 2013). "Recent progress in pancreatic cancer". CA: A Cancer Journal for Clinicians. 63 (5): 318–48. doi:10.3322/caac.21190. PMC 3769458. PMID 23856911.
Vincent A, Herman J, Schulick R, Hruban RH, Goggins M (اوت 2011). "Pancreatic cancer" (PDF). Lancet. 378 (9791): 607–20. doi:10.1016/S0140-6736(10)62307-0. PMC 3062508. PMID 21620466. Archived from the original (PDF) on 12 January 2015.
Larsson, S. C.; Wolk, A. (2012). "Red and processed meat consumption and risk of pancreatic cancer: meta-analysis of prospective studies". British Journal of Cancer. 106 (3): 603–607. doi:10.1038/bjc.2011.585. PMC 3273353. PMID 22240790.
Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. (GBD 2015 Mortality and Causes of Death Collaborators) (October 2016). "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015". The Lancet. 388 (10053): 1459–1544. doi:10.1016/s0140-6736(16)31012-1. PMC 5388903. PMID 27733281.
The PanNET denomination is in line with WHO guidelines for the classification of tumors of the digestive system "WHO classification of tumours of the digestive system – NLM Catalog – NCBI". Archived from the original on 9 September 2017. Retrieved 7 September 2017. published in 2010. Historically, PanNETs have also been referred to by a variety of terms, and are still commonly called "pancreatic endocrine tumors". See: Klimstra DS, Modlin IR, Coppola D, Lloyd RV, Suster S (August 2010). "The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems". Pancreas. 39 (6): 707–12. doi:10.1097/MPA.0b013e3181ec124e. PMID 20664470. S2CID 3735444.
Tsuchiya R, Noda T, Harada N, Miyamoto T, Tomioka T, Yamamoto K, Yamaguchi T, Izawa K, Tsunoda T, Yoshino R (1986). "Collective review of small carcinomas of the pancreas". Annals of Surgical Oncology. 203 (1). doi:10.1097/00000658-198601000-00013. PMC 1251042. PMID 3942423. Retrieved 7 May 2024.{{cite journal}}: نگهداری CS1: نقطه‌گذاری اضافه (link) نگهداری یادکرد:فرمت پارامتر PMC (link)
Pannala R, Basu A, Petersen GM, Chari ST (January 2009). "New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer". The Lancet. Oncology. 10 (1): 88–95. doi:10.1016/S1470-2045(08)70337-1. PMC 2795483. PMID 19111249.
Sperti C, Moletta L, Patanè G (October 2014). "Metastatic tumors to the pancreas: The role of surgery". World Journal of Gastrointestinal Oncology. 6 (10): 381–92. doi:10.4251/wjgo.v6.i10.381. PMC 4197429. PMID 25320654.
Bosetti C, Lucenteforte E, Silverman DT, Petersen G, Bracci PM, Ji BT, et al. (July 2012). "Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4)". Annals of Oncology. 23 (7): 1880–88. doi:10.1093/annonc/mdr541. PMC 3387822. PMID 22104574.
Hsu FC, Roberts NJ, Childs E, Porter N, Rabe KG, Borgida A, Ukaegbu C, Goggins MG, Hruban RH, Zogopoulos G, Syngal S, Gallinger S, Petersen GM, Klein AP (2021). "Risk of Pancreatic Cancer Among Individuals With Pathogenic Variants in the ATM Gene". JAMA Oncol. 7 (11): 1664–1668. doi:10.1001/jamaoncol.2021.3701. PMC 8446906. PMID 34529012. Retrieved 17 May 2024.
Hannan Z, Yu S, Domchek S, Mamtani R, Reiss KA (2021). "Clinical Characteristics of Patients With Pancreatic Cancer and Pathogenic ATM Alterations". JNCI Cancer Spectr. 5 (2): 1–4. doi:10.1093/jncics/pkaa121. PMC 7952223. PMID 33733050. Retrieved 17 May 2024.
Kory W. Jasperson, Randall W. Burt (1998), APC-Associated Polyposis Conditions
Reznik R, Hendifar AE, Tuli R (2014). "Genetic determinants and potential therapeutic targets for pancreatic adenocarcinoma". Frontiers in Physiology. 5: 87. doi:10.3389/fphys.2014.00087. PMC 3939680. PMID 24624093.
Hackeng WM, Hruban RH, Offerhaus GJ, Brosens LA (2016). "Surgical and molecular pathology of pancreatic neoplasms". Diagn Pathol. 11 (1): 47. doi:10.1186/s13000-016-0497-z. PMC 4897815. PMID 27267993.{{cite journal}}: نگهداری یادکرد:نام‌های متعدد:فهرست نویسندگان (link) (distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/)), Image title and optimization: Mikael Häggström, M.D.
Delpu Y, Hanoun N, Lulka H, Sicard F, Selves J, Buscail L, et al. (March 2011). "Genetic and epigenetic alterations in pancreatic carcinogenesis". Current Genomics. 12 (1): 15–24. doi:10.2174/138920211794520132. PMC 3129039. PMID 21886451.
Skafida E, Grammatoglou X, Glava C, Zissis D, Paschalidis N, Katsamagkou E, et al. (February 2010). "Adenosquamous carcinoma of the pancreas: a case report". Cases Journal. 3 (1): 41. doi:10.1186/1757-1626-3-41. PMC 2825199. PMID 20205828.
Adsay V, Mino-Kenudson M, Furukawa T, Basturk O, Zamboni G, Marchegiani G, et al. (January 2016). "Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting". Annals of Surgery. 263 (1): 162–77. doi:10.1097/SLA.0000000000001173. PMC 4568174. PMID 25775066.
Sun, J.; Li, Y.; Liu, L.; Jiang, Z.; Liu, G. (2019). "Aspirin use and pancreatic cancer risk: A systematic review of observational studies - PubMed". Medicine. 98 (51): e18033. doi:10.1097/MD.0000000000018033. PMC 6940047. PMID 31860953.
He XY, Yuan YZ (August 2014). "Advances in pancreatic cancer research: moving towards early detection". World Journal of Gastroenterology. 20 (32): 11241–48. doi:10.3748/wjg.v20.i32.11241. PMC 4145762. PMID 25170208.
Okano K, Suzuki Y (August 2014). "Strategies for early detection of resectable pancreatic cancer". World Journal of Gastroenterology. 20 (32): 11230–40. doi:10.3748/wjg.v20.i32.11230. PMC 4145761. PMID 25170207.
Goggins M, Overbeek KA, Brand R, Syngal S, Del Chiaro M, Bartsch DK, et al. (January 2020). "Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium". Gut. 69 (1): 7–17. doi:10.1136/gutjnl-2019-319352. PMC 7295005. PMID 31672839.
Jensen RT, Cadiot G, Brandi ML, de Herder WW, Kaltsas G, Komminoth P, et al. (2012). "ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes". Neuroendocrinology. 95 (2): 98–119. doi:10.1159/000335591. PMC 3701449. PMID 22261919.
Rossi RE, Massironi S, Conte D, Peracchi M (January 2014). "Therapy for metastatic pancreatic neuroendocrine tumors". Annals of Translational Medicine. 2 (1): 8. doi:10.3978/j.issn.2305-5839.2013.03.01. PMC 4200651. PMID 25332984.
Buanes TA (August 2014). "Pancreatic cancer-improved care achievable". World Journal of Gastroenterology. 20 (30): 10405–18. doi:10.3748/wjg.v20.i30.10405. PMC 4130847. PMID 25132756.
Are C, Dhir M, Ravipati L (June 2011). "History of pancreaticoduodenectomy: early misconceptions, initial milestones and the pioneers". HPB. 13 (6): 377–84. doi:10.1111/j.1477-2574.2011.00305.x. PMC 3103093. PMID 21609369.
Cameron JL, Riall TS, Coleman J, Belcher KA (July 2006). "One thousand consecutive pancreaticoduodenectomies". Annals of Surgery. 244 (1): 10–5. doi:10.1097/01.sla.0000217673.04165.ea. PMC 1570590. PMID 16794383.
Fernández-del Castillo C, Morales-Oyarvide V, McGrath D, Wargo JA, Ferrone CR, Thayer SP, et al. (September 2012). "Evolution of the Whipple procedure at the Massachusetts General Hospital". Surgery. 152 (3 Suppl 1): S56-63. doi:10.1016/j.surg.2012.05.022. PMC 3806095. PMID 22770961.
Reznik R, Hendifar AE, Tuli R (2014). "Genetic determinants and potential therapeutic targets for pancreatic adenocarcinoma". Frontiers in Physiology. 5: 87. doi:10.3389/fphys.2014.00087. PMC 3939680. PMID 24624093.
Biankin AV, Waddell N, Kassahn KS, Gingras MC, Muthuswamy LB, Johns AL, et al. (November 2012). "Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes". Nature. 491 (7424): 399–405. Bibcode:2012Natur.491..399.. doi:10.1038/nature11547. PMC 3530898. PMID 23103869.
Feng, Hui-Yi; Chen, Yang-Chao (2016-09-07). "Role of bile acids in carcinogenesis of pancreatic cancer: An old topic with new perspective". World Journal of Gastroenterology. 22 (33): 7463–7477. doi:10.3748/wjg.v22.i33.7463. ISSN 1007-9327. PMC 5011662. PMID 27672269.
Bruenderman EH, Martin RC (March 2015). "High-risk population in sporadic pancreatic adenocarcinoma: guidelines for screening". The Journal of Surgical Research. 194 (1): 212–9. doi:10.1016/j.jss.2014.06.046. PMC 4559279. PMID 25479908.
Tang SC, Chen YC (اوت 2014). "Novel therapeutic targets for pancreatic cancer". World Journal of Gastroenterology. 20 (31): 10825–44. doi:10.3748/wjg.v20.i31.10825. PMC 4138462. PMID 25152585.
Tanase CP, Neagu AI, Necula LG, Mambet C, Enciu AM, Calenic B, et al. (August 2014). "Cancer stem cells: involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics". World Journal of Gastroenterology. 20 (31): 10790–801. doi:10.3748/wjg.v20.i31.10790. PMC 4138459. PMID 25152582.
Tang SC, Chen YC (اوت 2014). "Novel therapeutic targets for pancreatic cancer". World Journal of Gastroenterology. 20 (31): 10825–44. doi:10.3748/wjg.v20.i31.10825. PMC 4138462. PMID 25152585.
Rossi ML, Rehman AA, Gondi CS (August 2014). "Therapeutic options for the management of pancreatic cancer". World Journal of Gastroenterology. 20 (32): 11142–59. doi:10.3748/wjg.v20.i32.11142. PMC 4145755. PMID 25170201.
Ady JW, Heffner J, Klein E, Fong Y (2014). "Oncolytic viral therapy for pancreatic cancer: current research and future directions". Oncolytic Virotherapy. 3: 35–46. doi:10.2147/OV.S53858. PMC 4918362. PMID 27512661.
Ren B, Cui M, Yang G, Wang H, Feng M, You L, Zhao Y (July 2018). "Tumor microenvironment participates in metastasis of pancreatic cancer". Molecular Cancer. 17 (1): 108. doi:10.1186/s12943-018-0858-1. PMC 6065152. PMID 30060755.

nlm.nih.gov

The Medical Subject Headings indexing system refers to "islet cell carcinoma", which is subdivided into gastrinoma, glucagonoma, somatostatinoma, and VIPoma. See: 2014 MeSH tree at "Pancreatic Neoplasms [C04.588.322.475]" بایگانی‌شده در ۱۹ مارس ۲۰۱۶ توسط Wayback Machine 16 October 2014

pmc.ncbi.nlm.nih.gov

Karoumpalis, Ioannis; Christodoulou, Dimitrios K (2016). "Cystic lesions of the pancreas". Annals of Gastroenterology. 29 (2): 155–161. doi:10.20524/aog.2016.0007. PMID 27065727. Retrieved 2 January 2025.

onkologia.org.pl

National Cancer Registry. "Pancreatic cancer (C25-C26)". Archived from the original on 2015-09-22. Retrieved 2015-09-22.

pancan.org

"Five-Year Pancreatic Cancer Survival Rate Increases to 12%". PANCAN. 2023. Archived from the original on 4 March 2023. Retrieved 3 March 2023.

pancreaticcancer.net.au

"Australian Pancreatic Genome Initiative". Garvan Institute. Archived from the original on 26 July 2014. Retrieved 17 July 2014.

pathologyoutlines.com

Image by Mikael Häggström, MD.
Reference for features: Pooja Navale, M.D., Omid Savari, M.D., Joseph F. Tomashefski, Jr., M.D., Monika Vyas, M.D. "Solid pseudopapillary neoplasm".{{cite web}}: نگهداری یادکرد:نام‌های متعدد:فهرست نویسندگان (link) Last author update: 4 March 2022
Diana Agostini-Vulaj. "Pancreas – Exocrine tumors / carcinomas – Intraductal papillary mucinous neoplasm (IPMN)". Pathology Outlines. Topic Completed: 1 July 2018. Revised: 9 March 2020

pcrf.org.uk

"Cancer facts and figures – Why we exist". Pancreatic Cancer Research Fund. Retrieved 5 April 2019.

proteinatlas.org

"The human pathology proteome in pancreatic cancer – The Human Protein Atlas". www.proteinatlas.org. Archived from the original on 3 July 2020. Retrieved 28 September 2017.

semanticscholar.org

api.semanticscholar.org

Bond-Smith G, Banga N, Hammond TM, Imber CJ (May 2012). "Pancreatic adenocarcinoma". BMJ. 344 (may16 1): e2476. doi:10.1136/bmj.e2476. PMID 22592847. S2CID 206894869.
Rohrmann, Sabine; et al. (2013). "Meat and fish consumption and risk of pancreatic cancer: Results from the European Prospective Investigation into Cancer and Nutrition". International Journal of Cancer. 132 (3): 617–624. doi:10.1002/ijc.27637. PMID 22610753. S2CID 2613568.
Elta, GH; Enestvedt, BK; Sauer, BG; Lennon, AM (April 2018). "ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts". The American Journal of Gastroenterology. 113 (4): 464–479. doi:10.1038/ajg.2018.14. PMID 29485131. S2CID 3584079.
The PanNET denomination is in line with WHO guidelines for the classification of tumors of the digestive system "WHO classification of tumours of the digestive system – NLM Catalog – NCBI". Archived from the original on 9 September 2017. Retrieved 7 September 2017. published in 2010. Historically, PanNETs have also been referred to by a variety of terms, and are still commonly called "pancreatic endocrine tumors". See: Klimstra DS, Modlin IR, Coppola D, Lloyd RV, Suster S (August 2010). "The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems". Pancreas. 39 (6): 707–12. doi:10.1097/MPA.0b013e3181ec124e. PMID 20664470. S2CID 3735444.
Burns WR, Edil BH (March 2012). "Neuroendocrine pancreatic tumors: guidelines for management and update". Current Treatment Options in Oncology. 13 (1): 24–34. doi:10.1007/s11864-011-0172-2. PMID 22198808. S2CID 7329783.
Rohrmann, Sabine; et al. (2013). "Meat and fish consumption and risk of pancreatic cancer: Results from the European Prospective Investigation into Cancer and Nutrition". International Journal of Cancer. 132 (3): 617–624. doi:10.1002/ijc.27637. PMID 22610753. S2CID 2613568.
Lewis MA, Yao JC (February 2014). "Molecular pathology and genetics of gastrointestinal neuroendocrine tumours". Current Opinion in Endocrinology, Diabetes and Obesity. 21 (1): 22–27. doi:10.1097/MED.0000000000000033. PMID 24310147. S2CID 31094880.
Fitzgerald JE, White MJ, Lobo DN (April 2009). "Courvoisier's gallbladder: law or sign?". World Journal of Surgery. 33 (4): 886–91. doi:10.1007/s00268-008-9908-y. PMID 19190960. S2CID 21799234.
Mollberg N, Rahbari NN, Koch M, Hartwig W, Hoeger Y, Büchler MW, Weitz J (December 2011). "Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis". Annals of Surgery. 254 (6): 882–93. doi:10.1097/SLA.0b013e31823ac299. PMID 22064622. S2CID 42685174.
Borazanci E, Von Hoff DD (September 2014). "Nab-paclitaxel and gemcitabine for the treatment of patients with metastatic pancreatic cancer". Expert Review of Gastroenterology & Hepatology. 8 (7): 739–47. doi:10.1586/17474124.2014.925799. PMID 24882381. S2CID 31633898.
Neoptolemos, Jp; Dunn, Ja; Stocken, Dd; Almond, J; Link, K; Beger, H; Bassi, C; Falconi, M; Pederzoli, P; Dervenis, C; Fernandez-Cruz, L (November 2001). "Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial". The Lancet (به انگلیسی). 358 (9293): 1576–1585. doi:10.1016/S0140-6736(01)06651-X. PMID 11716884. S2CID 23803289.
Falconi M, Bartsch DK, Eriksson B, Klöppel G, Lopes JM, O'Connor JM, et al. (2012). "ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors". Neuroendocrinology. 95 (2): 120–34. doi:10.1159/000335587. PMID 22261872. S2CID 6985904.
Pavel M, Baudin E, Couvelard A, Krenning E, Öberg K, Steinmüller T, et al. (2012). "ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary". Neuroendocrinology. 95 (2): 157–76. doi:10.1159/000335597. PMID 22262022. S2CID 2097604.
Castellano D, Grande E, Valle J, Capdevila J, Reidy-Lagunes D, O'Connor JM, Raymond E (June 2015). "Expert consensus for the management of advanced or metastatic pancreatic neuroendocrine and carcinoid tumors". Cancer Chemotherapy and Pharmacology. 75 (6): 1099–114. doi:10.1007/s00280-014-2642-2. PMID 25480314. S2CID 39434924.
Singh S, Dey C, Kennecke H, Kocha W, Maroun J, Metrakos P, et al. (August 2015). "Consensus Recommendations for the Diagnosis and Management of Pancreatic Neuroendocrine Tumors: Guidelines from a Canadian National Expert Group". Annals of Surgical Oncology. 22 (8): 2685–99. doi:10.1245/s10434-014-4145-0. PMID 25366583. S2CID 8129133.
Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007). "Cancer statistics, 2007". CA: A Cancer Journal for Clinicians. 57 (1): 43–66. doi:10.3322/canjclin.57.1.43. PMID 17237035. S2CID 22305510.
Graham JS, Jamieson NB, Rulach R, Grimmond SM, Chang DK, Biankin AV (September 2015). "Pancreatic cancer genomics: where can the science take us?". Clinical Genetics. 88 (3): 213–9. doi:10.1111/cge.12536. PMID 25388820. S2CID 26414866.
Weiss MJ, Wolfgang CL (2013). "Irreversible electroporation: a novel pancreatic cancer therapy". Current Problems in Cancer. 37 (5): 262–5. doi:10.1016/j.currproblcancer.2013.10.002. PMID 24331180. S2CID 3137300.

springer.com

link.springer.com

Satoshi Kondo. "Japanese Pancreas Society Staging Systems for Pancreatic Cancer". Pancreatic cancer. Springer New York. doi:10.1007/978-0-387-77498-5_42. ISBN 978-0-387-77497-8.
Sachi Das, Sabya; Kumar Dubey, Amit; Singh, Neeru; Ranjan, Priya; Verma, Prasad; Kumar Singh, Shubhankar; Kumar Singh, Sandeep (2023-01-09). "Pancreatic Cancer Treatment by Using Theragnostic Nanoparticles". Hormone Related Cancer Mechanistic and Nanomedicines. pp. 149–168. doi:10.1007/978-981-19-5558-7_8. ISBN 978-981-19-5557-0.

springer.de

link.springer.de

Kobari M, Matsuno S (1998). "Staging systems for pancreatic cancer: differences between the Japanese and UICC systems". J Hepatobiliary Pancreat Surg. 5 (2): 121–7. PMID 9745076. Archived from the original on 18 May 2024.

uptodate.com

"Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer". UpToDate. 2024. Retrieved 8 May 2024.
Ryan DP (8 ژوئیه 2014). "Chemotherapy for advanced exocrine pancreatic cancer: Topic 2475, Version 46.0" (subscription required). UpToDate. Wolters Kluwer Health. Archived from the original on 8 December 2014. Retrieved 18 November 2014.

uspreventiveservicestaskforce.org

"Draft Recommendation Statement: Pancreatic Cancer: Screening". US Preventive Services Task Force. Retrieved 11 February 2019.

wcrf.org

"Pancreatic cancer statistics". wcrf.org. World Cancer Research Fund. 2025. Archived from the original on 11 January 2025. Retrieved 11 January 2025.
"Pancreatic cancer statistics". wcrf.org. World Cancer Research Fund. 2025. Archived from the original on 11 January 2025. Retrieved 11 January 2025.

web.archive.org

"Pancreatic Cancer Treatment (PDQ®) Patient Version". National Cancer Institute. National Institutes of Health. 17 April 2014. Archived from the original on 5 July 2014. Retrieved 8 June 2014.
Vincent A, Herman J, Schulick R, Hruban RH, Goggins M (اوت 2011). "Pancreatic cancer" (PDF). Lancet. 378 (9791): 607–20. doi:10.1016/S0140-6736(10)62307-0. PMC 3062508. PMID 21620466. Archived from the original (PDF) on 12 January 2015.
"Can pancreatic cancer be prevented?". American Cancer Society. 11 June 2014. Archived from the original on 13 November 2014. Retrieved 13 November 2014.
"Five-Year Pancreatic Cancer Survival Rate Increases to 12%". PANCAN. 2023. Archived from the original on 4 March 2023. Retrieved 3 March 2023.
"PANCREAS" (PDF). gco.iarc.who.int. The Global Cancer Observatory (GCO). 2025. Archived from the original (PDF) on 11 January 2025. Retrieved 11 January 2025.
"Pancreatic cancer statistics". wcrf.org. World Cancer Research Fund. 2025. Archived from the original on 11 January 2025. Retrieved 11 January 2025.
"What Is Cancer? Defining Cancer". National Cancer Institute, National Institutes of Health. 7 March 2014. Archived from the original on 25 June 2014. Retrieved 5 December 2014.
"Pancreatic cancer statistics". wcrf.org. World Cancer Research Fund. 2025. Archived from the original on 11 January 2025. Retrieved 11 January 2025.
"Pancreatic Cancer Treatment (PDQ®) Health Professional Version". National Cancer Institute. National Institutes of Health. 21 February 2014. Archived from the original on 22 October 2014. Retrieved 24 November 2014.
Harris RE (2013). "Epidemiology of pancreatic cancer". Epidemiology of Chronic Disease. Jones & Bartlett. pp. 181–190. ISBN 978-0-7637-8047-0. Archived from the original on 24 June 2016.
Handbook of Pancreatic Cancer. New York: Springer. 2009. p. 288. ISBN 978-0-387-77497-8. Archived from the original on 10 September 2017. Retrieved 12 June 2016.
"Types of Pancreas Tumors". The Sol Goldman Pancreas Cancer Research Center. Johns Hopkins Medicine. 2012. Archived from the original on 8 October 2014. Retrieved 18 November 2014.
The PanNET denomination is in line with WHO guidelines for the classification of tumors of the digestive system "WHO classification of tumours of the digestive system – NLM Catalog – NCBI". Archived from the original on 9 September 2017. Retrieved 7 September 2017. published in 2010. Historically, PanNETs have also been referred to by a variety of terms, and are still commonly called "pancreatic endocrine tumors". See: Klimstra DS, Modlin IR, Coppola D, Lloyd RV, Suster S (August 2010). "The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems". Pancreas. 39 (6): 707–12. doi:10.1097/MPA.0b013e3181ec124e. PMID 20664470. S2CID 3735444.
The Medical Subject Headings indexing system refers to "islet cell carcinoma", which is subdivided into gastrinoma, glucagonoma, somatostatinoma, and VIPoma. See: 2014 MeSH tree at "Pancreatic Neoplasms [C04.588.322.475]" بایگانی‌شده در ۱۹ مارس ۲۰۱۶ توسط Wayback Machine 16 October 2014
"Islet Cell Tumors of the Pancreas / Endocrine Neoplasms of the Pancreas". The Sol Goldman Pancreas Cancer Research Center. Johns Hopkins Medicine. 2012. Archived from the original on 5 January 2015. Retrieved 5 January 2015.
"Chapter 15; Pancreas" (PDF). Manual for Staging of Cancer (2nd ed.). American Joint Committee on Cancer. pp. 95–98. Archived (PDF) from the original on 29 November 2014. See p. 95 for citation regarding "... lesser degree of involvement of bones and brain and other anatomical sites."
Lowenfels, A.B.; Maisonneuve, P. (2004). "Epidemiology and prevention of pancreatic cancer". Jpn J Clin Oncol. 34 (5): 238–244. PMID 15231857. Archived from the original on 9 July 2011. Retrieved 16 May 2024.{{cite journal}}: نگهداری یادکرد:ربات:وضعیت نامعلوم پیوند اصلی (link)
"Cancer Facts and Figures 2014" (PDF). American Cancer Society. Archived (PDF) from the original on 18 December 2014. Retrieved 5 January 2015., p. 19, "Though evidence is still accumulating, consumption of red or processed meat, or meat cooked at very high temperatures, may slightly increase risk."
National Cancer Registry. "Pancreatic cancer (C25-C26)". Archived from the original on 2015-09-22. Retrieved 2015-09-22.
"The human pathology proteome in pancreatic cancer – The Human Protein Atlas". www.proteinatlas.org. Archived from the original on 3 July 2020. Retrieved 28 September 2017.
"Nowotwory części zewnątrz- i wewnątrzwydzielniczej trzustki. Klasyfikacja TNM". Archived from the original on 2015-10-03. Retrieved 2015-10-03.
Kobari M, Matsuno S (1998). "Staging systems for pancreatic cancer: differences between the Japanese and UICC systems". J Hepatobiliary Pancreat Surg. 5 (2): 121–7. PMID 9745076. Archived from the original on 18 May 2024.
"Staging of pancreatic cancer". American Cancer Society. 11 June 2014. Archived from the original on 10 August 2020. Retrieved 29 September 2014.
Zyromski, Nicholas J.; Nakeeb, Attila; Lillemoe, Keith D. (2010). Silberman, Howard; Silberman, Allan W. (eds.). Principles and practice of surgical oncology : multidisciplinary approach to difficult problems (online ed.). Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins. Chapter 35. ISBN 978-0-7817-6546-6. Archived from the original on 6 February 2015. Retrieved 3 November 2014.
National Cancer Institute. Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Treatment (PDQ®) Incidence and Mortality "Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Treatment (PDQ®)–Health Professional Version". Archived from the original on 4 January 2015. Retrieved 29 December 2014.
"Diet and activity factors that affect risks for certain cancers: Pancreatic cancer section". American Cancer Society. 20 August 2012. Archived from the original on 4 November 2014. Retrieved 4 November 2014.
Ryan DP (8 ژوئیه 2014). "Chemotherapy for advanced exocrine pancreatic cancer: Topic 2475, Version 46.0" (subscription required). UpToDate. Wolters Kluwer Health. Archived from the original on 8 December 2014. Retrieved 18 November 2014.
"Cancer Drug Information: FDA Approval for Erlotinib Hydrochloride". National Cancer Institute. National Institutes of Health. 3 ژوئیه 2013. Archived from the original on 29 November 2014. Retrieved 5 December 2014.
Nick Mulcahy (17 December 2014). "FDA Approves Lanreotide for Neuroendocrine Tumors". Medscape Medical News. WebMD LLC. Archived from the original on 18 January 2015. Retrieved 25 December 2014.
Everolimus Approved for Pancreatic Neuroendocrine Tumors بایگانی‌شده در ۱۶ ژوئیه ۲۰۱۶ توسط Wayback Machine The ASCO Post. 15 May 2011, Volume 2, Issue 8
National Cancer Institute. Cancer Drug Information. FDA Approval for Sunitinib Malate بایگانی‌شده در ۵ ژانویه ۲۰۱۵ توسط Wayback Machine. Pancreatic Neuroendocrine Tumors
Text is available electronically (but may require free registration) See: Benson AB, Myerson RJ, Sasson AR (2010). Pancreatic, neuroendocrine GI, and adrenal cancers. Cancer Management: A Multidisciplinary Approach (13th ed.). UBM Medica. ISBN 978-0-615-41824-7. Archived from the original on 15 May 2011.
"Palliative or Supportive Care". American Cancer Society. 2014. Archived from the original on 21 August 2014. Retrieved 20 August 2014.
"If treatment for pancreatic cancer stops working". American Cancer Society. 11 June 2014. Archived from the original on 22 October 2014. Retrieved 20 August 2014.
"Cancer Facts and Figures 2014" (PDF). American Cancer Society. Archived (PDF) from the original on 18 December 2014. Retrieved 5 January 2015., Table, p. 18, rates adjusted for normal life expectancy
"What are the key statistics about pancreatic cancer?". American Cancer Society. 11 June 2014. Archived from the original on 11 November 2014. Retrieved 11 November 2014.
"Pancreatic cancer statistics". Cancer Research UK. Archived from the original on 18 December 2014. Retrieved 18 December 2014.; "In 2010, in the UK, the lifetime risk of developing pancreatic cancer is 1 in 73 for men and 1 in 74 for women", noting "The lifetime risk ... has been calculated ... using the 'Current Probability' method; this is a different method used from most other cancer sites since the possibility of having more than one diagnosis of pancreatic cancer over the course of their lifetime is very low"
"Pancreatic cancer research". Cancer Research UK. Archived from the original on 18 February 2014. Retrieved 17 July 2014.
"Australian Pancreatic Genome Initiative". Garvan Institute. Archived from the original on 26 July 2014. Retrieved 17 July 2014.
"About EUROPAC". European Registry of Hereditary Pancreatitis and Familial Pancreatic Cancer (EUROPAC). University of Liverpool. Archived from the original on 26 July 2014. Retrieved 17 July 2014.

who.int

gco.iarc.who.int

"PANCREAS" (PDF). gco.iarc.who.int. The Global Cancer Observatory (GCO). 2025. Archived from the original (PDF) on 11 January 2025. Retrieved 11 January 2025.

wiley.com

onlinelibrary.wiley.com

Bilimoria, K.Y.; Bentrem, D.J.; Ko, C.Y.; Ritchey, J.; Stewart, A.K. (2007). "Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database". Cancer. 110 (4): 738–744. doi:10.1002/cncr.22852. PMID 17580363.

worldcat.org

Neoptolemos, John P.; Stocken, Deborah D.; Friess, Helmut; Bassi, Claudio; Dunn, Janet A.; Hickey, Helen; Beger, Hans; Fernandez-Cruz, Laureano; Dervenis, Christos; Lacaine, François; Falconi, Massimo (2004-03-18). "A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer". New England Journal of Medicine (به انگلیسی). 350 (12): 1200–1210. doi:10.1056/NEJMoa032295. ISSN 0028-4793. PMID 15028824.
Feng, Hui-Yi; Chen, Yang-Chao (2016-09-07). "Role of bile acids in carcinogenesis of pancreatic cancer: An old topic with new perspective". World Journal of Gastroenterology. 22 (33): 7463–7477. doi:10.3748/wjg.v22.i33.7463. ISSN 1007-9327. PMC 5011662. PMID 27672269.

wustl.edu

hpbgisurgery.wustl.edu

"Pancreatic Cancer". hpbgisurgery.wustl.edu. Department of Surgery - Washington University in St. Louis. December 2024. Retrieved 29 December 2024.

zju.edu.cn

m-learning.zju.edu.cn

Vincent A, Herman J, Schulick R, Hruban RH, Goggins M (اوت 2011). "Pancreatic cancer" (PDF). Lancet. 378 (9791): 607–20. doi:10.1016/S0140-6736(10)62307-0. PMC 3062508. PMID 21620466. Archived from the original (PDF) on 12 January 2015.